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Abstract : Abnormalities of Cardiovascular Structure As Mediators of the
Association ofHigh Blood Pressure, Insulin Resistance and Low Birthweight.
Many studies have demonstrated associations between low birthweight and higher
subsequent blood pressure, insulin resistance and greater incidence of coronary heart
disease. These findings suggest that the origins of vascular disease are to be found
during intra-uterine life, and that the low birthweight individual may be
"programmed" to develop vascular disease. This hypothesis suggests that the
development of the individual is permanently altered by its response to the
environmental conditions that are responsible for low birthweight. At present,
evidence of altered functioning of potential mechanisms that might be susceptible to
programming is beginning to emerge.
Increased vascular resistance is the hallmark of hypertension, and of the components
of the vascular tree, microvessels contribute the greatest proportion to vascular
resistance. Abnormalities ofmicrovessels have been identified at early stages in the
development of high blood pressure, and may contribute to variations in glucose
homeostasis by limiting glucose uptake by metabolically active tissue. Thus if
vascular structure is altered by the intrauterine environment it would have the
potential to mediate associations with adult cardiovascular risk factors.
The introduction to this thesis reviews key papers describing associations between
early life and adult cardiovascular risk factors. Factors that alter birthweight are
considered in detail, especially the effect of gestational age, which has been
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relatively neglected in previously published work. The chapter concludes with a
review of the field of microvascular structure and hypertension.
The experimental chapters describe studies performed in three cohorts of healthy
young people. The first cohort comprises 61 survivors of premature delivery or
control individuals born at term. We demonstrated higher adult blood pressure,
glucose and lipids in adult premature babies irrespective of whether they had been
exposed to IUGR. Chapter 3 documents indices of cardiac and vascular structure in
this cohort. We demonstrated that low birthweight in this cohort was associated with
greater left ventricular mass, over and above the effect from the higher blood
pressure in these individuals.
Chapter 4 describes the influence of birthweight, current size and parental size on
blood pressure in a cohort of 107 boys attending a fee-paying school. Low
birthweight is associated with higher blood pressure after adjustment for current size,
but is not associated with parental influence on current size. We also measured
dermal capillary density in these boys but did not demonstrate associations with
blood pressure or birthweight. Chapter 5 investigates associations between structure
and function ofmicrovessels, and blood pressure, insulin resistance and fasting
plasma glucose concentrations in 105 healthy young men. We did not find evidence
that insulin resistance was associated with altered structure or function of
microvessels, although both higher blood pressure and higher blood glucose were
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Vascular disease awaits all of us. In modern times, we are likely to elude premature
death from infectious or neoplastic causes, and will become susceptible to the
ubiquitous morbidity and mortality that result from atheromatous degeneration of
conduit arteries. The clinical manifestations ofmyocardial ischaemia and infarction,
stroke, and renal failure are the culmination of many years of pathophysiological
processes. The rate of progression to clinical manifestations in individuals relates to
a collection of risk factors which have been acknowledged for many years - cigarette
smoking, high blood pressure, and disordered metabolism of glucose and of lipids.
Observations that events during intra-uterine, and early post-natal life might
influence the development of conditions in the twilight years have been hailed as "a
breath of fresh air to both perinatal and cardiovascular disease epidemiology"
(KRAMER 1996). This is a relatively young field which has developed since 1986.
Many associations between early life and indices of vascular disease risk and
mortality have been described. The most consistent observation is an association
between low birthweight and higher blood pressure in childhood and adulthood, and
this is also the main emphasis of this thesis. Low birthweight is also associated with
increased prevalence of glucose intolerance, disordered lipid metabolism and higher
cardiovascular mortality. Other indices of size at birth: length, thinness,
circumference of head and abdomen, ratio of placental size to birthweight have also
correlated with increased cardiovascular risk. (BARKER 1990, JOSEPH 1996,
THAME 2000)
11
Many of the studies describing the adult associations have used data preserved by
chance, which has been not collected with the intention of exploring potential
confounding influences on associations with adult outcomes. Causation has been
asserted for associations between birthweight and adult outcomes, but at present this
is essentially speculative. Factors influencing birthweight may potentially
programme the individual, and have a causative effect on adult outcomes.
Alternatively low birthweight may be a marker for individuals who will develop
adult outcomes that have been influenced through genetic or environmental
influences acting during adult life, with no causative mechanisms operating in early
life. Most of the studies published in this field are observational; there are many
practical and ethical problems with an experimental approach to this question, at
least in humans, the question of causality will not be answered for some time.
Professor Barker and colleagues who are based in Southampton have published
many of the studies that will be cited in this thesis. The group has reproduced their
initial observations in many populations throughout the world, and established a
theoretical framework for elucidating underlying mechanisms. The rapid
development of the field is due in no small measure to their energy.
In this thesis, an initial introduction will examine in detail key observations that are
representative of many studies that describe these associations. I will expand
definitions of programming and discuss alternative interpretations of the
associations. Having set out this stall, I will consider what processes are represented
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by measurements of birthweight and infant size. Early development could influence
subsequent vascular physiology in a plethora of ways. The next section will consider
potential mechanisms. The experimental studies that I performed pursued the
hypothesis that vascular structure might be altered by early development; this
chapter concludes with a detailed review of vascular structure in hypertension, and
an outline of the theoretical basis to support investigation in this area.
Key observations
Ecologic evidence
One of the first studies to link cardiovascular mortality with conditions in early life
examined disease prevalence rates in each of 212 local authorities in England and
Wales. The authors noted a strong correlation (r=0.73) between infant mortality in
1921-25 (291 082 deaths) and ischaemic heart disease mortality rates between 1968
and 1978 (922 834 deaths). Correlations with other disease processes were also
noted: Bronchitis (r=0.82), stomach cancer (r=0.79), stroke (r=0.54), and lung cancer
(r=0.46). The associations were consistent across age ranges of adults, and between
sexes. Infant mortality is divisible into neonatal (first month after delivery) and post-
neonatal. Correlations with ischaemic heart disease mortality were similar for both
neonatal (r=0.69), and post-neonatal (r=0.68), whereas for chronic bronchitis
(r=0.58, vs. p=0.83 respectively), and lung cancer (r=0.13, vs. r=0.55) post-neonatal
mortality was the stronger predictor. Post-neonatal death was most commonly due to
respiratory illness suggesting a common link with social conditions and cigarette
13
smoking. Neonatal death was ascribed to congenital causes in 80% of cases.
(BARKER 1986)
These results were interpreted to indicate that influences on intra-uterine life may
predispose to coronary heart disease in later life, and suggests maternal and infant
nutrition as a potentially causative factor.
Earlier claims to originality
An editorial in the BMJ (Early origin of coronary heart disease (the "Barker
hypothesis")) (PANETH 1995) provoked a letter from Norwegian academics
(GRAM 1995), noting that ecologic associations between poverty in childhood and
later cardiovascular disease had been described long before the paper that is
normally credited as the original description (BARKER 1986). This earlier paper
(FORSDAHL 1973) was written in Norwegian which may explain its lack of
prominence, although another paper by Forsdahl (FORSDAHL 1977) was cited in
the Barker paper. This thesis will not adjudicate on ownership of eponymous status.
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Low birthweight and higher blood pressure
The association between low birthweight and higher subsequent blood pressure has
been comprehensively reviewed by Huxley et al. (HUXLEY 2000) These authors
have built upon their earlier review (LAW 1996) which identified 34 studies
published up to March 1996. 46 further studies were published up to March 2000.
They excluded a further 18 studies from the original review, and 12 from 1996 to
2000. Studies were excluded if published only in abstract form, if the paper did not
describe the magnitude of change in blood pressure associated with birthweight, or if
all participants were drawn from a "pathological group", such as prematurity.
These reviews record numbers, age and sex of participants, location of study, mean
birth weight and blood pressure of participants and the strength of the association (as
regression coefficients with confidence intervals). The strength of the association
was typically 2-3 mmHg/kg birthweight, after adjustment for current size, in the
1996 review and l-2mmHg/kg in the 2000 review. Thus the difference in blood
pressure attributable to birthweight is approximately 6-8 mmHg. This is similar in
magnitude to the blood pressure lowering effect of a single anti-hypertensive agent,
which can be clinically significant for an individual. We should note that the
association between birthweight and blood pressure pertains to the entire range of
birthweight and not merely a tendency for very low birth weight babies to develop
hypertension.
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I do not propose to reproduce the information summarised in these reviews. I will
describe in detail a few studies that made key observations in different patient
groups, and general points about the extent to which these observations have been
reproduced in other population samples.
Adulthood
Evidence relating intra-uterine factors to adult disease in individual patients,
followed from the discovery of unusually detailed birth records for in-hospital births
in two cohorts in England: East Hertfordshire and Preston. Individuals who had not
moved away from the area were traced and invited to participate in studies of
cardiovascular risk.
Of 1298 men and women, born in the labour ward at Sharoe Green Hospital, Preston,
Lancashire between 1935 and 1943, 449 were traced and agreed to participate
(BARKER 1990). In this cohort higher blood pressure was predicted by lower
birthweight (11 mmHg (95% C.I. 3-19 mmHg) higher in the quintile with lowest
birth weight than the greatest). This study showed that greater placental weight
predicted higher blood pressure, independently from birthweight (15 mmHg (95%
C.I. 8-23 mmHg) higher in the tertile with greatest placental weight). Information
on social class at birth or at the time of the study did not seem to confound the
relationship between placental weight and blood pressure; no statistical test is
quoted. The authors acknowledge that hospital birth was less prevalent at that time
although inspection of the records does not suggest that mothers were ill, as many of
the beds had been booked early in pregnancy.
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The Hertfordshire blood pressure data was published along with 3 other cohorts
(LAW 1993). For individuals born in Hertfordshire, a 1kg decrease in birthweight
predicted a 4.0 mmHg increase in blood pressure, although this was not significant in
female subjects. With the other cohorts, it appeared that the inverse relationship with
birthweight became stronger as the age of the subjects increased. This has not been
supported by all further studies.
These observations have been repeated in 20 populations reporting multiple
regression analyses (HUXLEY 2000). After adjusting for current size, in all but
three, an inverse relationship between birthweight and blood pressure was shown
(95% confidence intervals traversed zero in 9 of these cohorts).
Childhood
Blood pressure is known to increase, and to track throughout childhood. Individuals
tend to maintain their rank within the population, at least until the onset of
adolescence (LEVER 1992). Blood pressure in childhood is also predictive of blood
pressure in adulthood.
In a long-term follow up study of 1739 individuals performed in Farnborough
(LAW 1993), individuals with lower birthweight had a tendency to have higher
blood pressure at annual measurements up until the age of 10 years.
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Whincup et al. performed repeated measures of blood pressure in children attending
primary schools in Guildford and Carlisle (WHINCUP 1989, WHINCUP 1995). At
5-7 years of age, low birthweight predicted higher systolic BP (1.83 mmHg/ kg, 95%
C.I. 1.31 - 2.35). This relationship was stronger at age 9-llyears for both systolic
(2.80 mmHg/kg, 95% C.I. 3.84 to 1.76) and diastolic BP (1.42 mmHg/kg, 2.14 to
0.70) after adjustment for current size. Lower birthweight predicted greater increase
in blood pressure between the two measurements (1.71 mmHg/kg decrease in
birthweight, 95% C.I. 3.35 to 0.07).
In the recent review (HUXLEY 2000) 17 papers report multiple regression analyses
of birthweight and systolic blood pressure. 15 showed an inverse association which
achieved statistical significance in 8 of these.
Adolescence
Many studies of blood pressure in adolescence have not demonstrated significant
associations between birth weight and blood pressure (HUXLEY 2000, MATTHES
1994). It has been suggested that tracking (maintenance of rank within the
population) of blood pressure is disturbed by rapid somatic growth (LEVER 1992).
This may weaken the association below the threshold at which it can be detected by
small studies.
Two very large studies have matched data on blood pressure, collected at
compulsory medical examinations on conscripts into armed services (LEON 2000,
SEIDMAN 1991). Linkage with centrally held birth records was possible through the
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unique national identification number of every participant. In the Israeli study of 32
580 recruits (SEIDMAN 1991), there was a weak, positive correlation between
birthweight and blood pressure in conscripts, whether or not current size was
adjusted for. The Swedish study (NILSSON 1997) of 149 378 recruits showed an
inverse association between birthweight and blood pressure (0.78 mmHg (95% C.I.
0.64 - 0.92) per kg birthweight). Interestingly, a reanalysis of a more complete
dataset (165 136 subjects) was published by a different group of authors (LEON
2000) which also showed an independent association with gestational age (0.136
mmHg (0.94 - 0.178) per week of prematurity. Huxley et al. (HUXLEY 2000)
identified 20 studies published on measures of blood pressure in adolescence. An
inverse relationship with birthweight is shown in 14, a positive relationship in 4 and
contrasting results in male and female subjects in 2.
Birthweight and other risk factors
Glucose intolerance and diabetes mellitus
The first report of an association between low birthweight and glucose intolerance
was in 468 men, average age 64 years, from the Hertfordshire cohort who had
undergone oral glucose tolerance testing (OGTT). Impaired glucose tolerance was
found in 30% of subjects < 5.5 pounds birthweight versus 14% in >9.5 pounds
(HALES 1991). Similarly in young men (21 years) 30 minute plasma glucose levels
after OGTT was inversely related to birthweight (ROBINSON 1992). Prevalence of
diabetes in 60 year old Swedish men was inversely related to birthweight, after
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adjustment for current BMI (LITHELL 1996). Pima Indians from Arizona have a
remarkably high incidence of NIDDM. A study of offspring demonstrated a U
shaped relationship between diabetes incidence and birthweight (MCCANCE 1994).
The higher incidence in individuals with higher birthweight was largely explained by
maternal gestational diabetes. The authors note that individuals with low birthweight
accounted for 6% of the overall incidence of diabetes, and suggest that these
individuals may have had a survival advantage from insulin resistance, as many low
birthweight babies in this population die in infancy. This would explain the
association without invoking programming.
Lipid disorders
Elevated triglyceride levels (1.6 mmol/1 vs 1.2) and decreased HDL levels (1.32
mmol/1 vs 1.57) were reported in women in the lowest and highest birthweight
quintiles, respectively (FALL 1995).
Low Birthweight and Coronary Artery Disease
This association occupies a small portion of this thesis, as the experimental studies
relate to mechanisms which might explain the association with blood pressure.
Clearly, the relationship between premature mortality and low birthweight is of
greater importance to public health.
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Following up their initial observation (BARKER 1986), Barker and colleagues
unearthed detailed birth records for infants born in Hertfordshire between 1911 and
1930. They matched birth records with mortality data for 5654 men. Death from
cardiovascular causes was higher in men who were lighter at birth, and especially in
men who were lighter at one year of age. (BARKER 1989 Lancet)
Low birthweight also predicted higher incidence of coronary artery disease (fatal and
non-fatal) in a cohort of 3447 Finnish women. Length at birth was a much stronger
predictor in this cohort. A large study (LEON 1998), with 14 611 participants and
remarkably complete follow up showed that low birthweight predicted increased
cardiovascular mortality in men.
A similar trend in coronary disease incidence was observed in a smaller cohort (517
people) born in Mysore, India (STEIN 1996), and in the American Nurses Study
(RICH-EDWARDS 1997). This very large study of 70 297 women demonstrated
relative risk of non-fatal first incidence of cardiovascular event decreasing from 1.49
in the lowest birthweight group to 0.68 in the highest.
Other infant measurements and later risk factors
Many other infant measurements have been shown to correlate with indices of
vascular risk. It is difficult to draw consistent conclusions from these data. Many of
the studies are contradictory (HUXLEY 2000, JOSEPH 1996), and doubt remains as
to what precise processes are reflected in relative dimensions of cranial or abdominal
circumference, or placental weight.
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Potential Mechanisms: Programming
One potential explanation of these observations is that development of structure and
function of organs and systems could be permanently influenced by conditions
during early life. Initial development is a plastic process, and may be limited by
environmental influences imposed upon the genetic blueprint. For example, cellular
proliferation contributes to organ growth for a limited timespan. Subsequently,
differentiated cells lose the ability to divide. If a planned expansion of cell numbers
fails to occur at the correct time, this may impose functional limits upon that organ
throughout the life of the organism. Adaptations that optimise function to the
prevailing conditions in a growth retarded foetus, would become maladaptions in a
nutritionally replete adult, manifested for example, as insulin resistance or higher
blood pressure. Barker cites (BARKER 1998) development of sweat glands as an
example of development in which conditions during a crucial window dictate
subsequent sweat gland density. Babies are born with a greater density of sweat
glands than adults have. Children exposed to a hot climate before 3 years of age
retain a greater proportion of their sweat glands. Sexual differentiation has been
recognised for many years to depend upon a surge of male hormones to change the
phenotype that would otherwise be female. (SADLER 1985A)
Functional limitations in control mechanisms might be programmed by a similar
process, establishing feedback loops that respond within different limits in the
organism that was exposed to the programming stimulus.
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Prenatal or postnatal influences?
Birthweight is the summary ofmany factors that influence intrauterine development.
It is important to bear in mind that it may also predict subsequent postnatal
development. This section considers interpretations of the existing studies in
humans, that suggest events and processes occurring during postnatal development
may be more important in determining adult outcomes.
A close relationship between the normal rise in blood pressure and childhood growth
has been identified for many years (LEVER 1992). Lever and Harrap (LEVER 1992)
proposed that the origins of essential hypertension may lie in mismatching of the rise
in blood pressure and bodily growth in childhood, followed by self perpetuating
mechanisms in adulthood. The central role of the kidney in maintenance of blood
pressure (GUYTON 1972), and the requirement for increased blood pressure to
maintain renal homeostasis during somatic growth, has led to speculation (WEDER
1994) that disproportion between kidney volume and body size in childhood would
be a potent initiator of hypertension.
It may be that environmental factors influence this mismatching, but interactions
between genetic factors are in themselves extremely complex. Establishing the role




In many studies, associations with birthweight are not seen unless adult factors (in
the studied individual, not their parents) are adjusted for. For some adult factors a
direct association with birthweight is unlikely for example cigarette smoking, or
alcohol intake. These factors could be proxy for socio-economic deprivation, which
is a separate issue (see deprivation section below). Most studies adjust blood
pressure for adult size, using height, weight or body mass index. The authors argue
that obesity is positively associated with both birthweight and blood pressure and
may thus obscure the inverse relationship between birthweight and blood pressure.
Lucas et al have argued that to adjust birthweight for adult size in multiple
regression analysis in effect describes the association between blood pressure and
growth velocity between the two measurements of size (LUCAS 1999). It is known
that many low birthweight babies grow at a faster rate during early childhood,
although babies with severe IUGR tend not to undergo "catch-up growth". Barker
and colleagues have argued that the programming influences on the baby predispose
it to gain weight as an infant. An alternative, equally valid interpretation is that low
birthweight may be a marker for babies that will undergo rapid catch up growth,
which is the mechanistic determinant. Associations between adult obesity and blood
pressure are, in general, stronger than those between birthweight and blood pressure.
From a public health perspective, adulthood obesity is therefore more important.
(PANETH 1995)
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Lucas et al. (LUCAS 1999) argue that intermediate sizes in large longitudinal
studies will help resolve this issue. Weight at, for example, one year is included in a
simultaneous multiple regression model with birthweight and adult weight,
predicting systolic blood pressure. If the association with birthweight is weakened it
implies that growth between one year and adulthood is the important determinant of
blood pressure. If the relationship with birthweight is strengthened then the model
suggests that earlier factors are likely to be important. To date few studies have had
measurements recorded at multiple time points, and no papers have published
analyses along these lines.
Postnatal growth and blood pressure
In the review by Huxley et al. (HUXLEY 2000) 3 studies report positive associations
between skeletal growth, that is to say adult height relative to birthweight, and blood
pressure. 13 studies report associations between blood pressure and weight gain, or
non-skeletal growth, 9 of these report a positive outcome.
Postnatal growth and cardiovascular mortality
Studies of incidence of overt clinical vascular disease have demonstrated different
associations in men and women. Risk in women relates to length at birth and linear
growth (FORSEN 1999), and in men relates to thinness at birth and increase in
weight (ERIKSSON 1999). Neither study examined the data specifically to test
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whether postnatal growth explained the association better than indices of foetal
growth.
In summary, it has not yet been established that low birthweight predicts higher adult
blood pressure through programming, which could occur during intrauterine life or
later. This issue will be addressed in the experimental chapters of the thesis.
Influences on Birthweight
Interpretation of the associations described above requires understanding of the
processes that lead to differences in birthweight. This section considers these factors
in detail, and the current state of knowledge regarding our ability to alter them.
Birthweight is the sum of many influences on the developing foetus, both
environmental and genetic, and the relative strength of these factors will vary
between individuals. Most research on prediction and outcome of low birthweight
has been performed by Obstetricians or Neonatologists, and the main outcome
measures are neonatal. Many studies are designed to identify individuals in
pathological groups, identifying intrauterine growth restriction (IUGR) as occurring
in babies below the tenth centile of weight for gestational age, and premature babies
having gestational ages <37 completed weeks. These babies are at high risk of
adverse neonatal outcomes. Low birthweight is a risk factor for perinatal morbidity
but 50% of British babies below the 3rd centile of birthweight at term, are
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proportionally small and have no obstetric or neonatal complications. (CHARD
1993)
In 1948 the World Health Assembly defined premature delivery (less than 37 weeks
gestation) as having occurred in all babies born weighing less than 2500g. Over the
following decades it became apparent that one third of these babies were not
premature, but were in fact inappropriately small. Normal foetal growth, in
Caucasian populations, was defined in 2 papers published in 1966 (GRUENWALD
1966, SCOTT 1966). With the development of ultrasound, standard tables for foetal
growth have been developed. (DETER 1992)
Because of the complexity of the influences on birthweight, beyond a statement that
"large mothers tend to have large babies" (CHARD 1993), it is difficult to precisely
quantify the genetic potential of individual babies. Maternal size has a stronger
association with birthweight, and indeed adult size, than paternal size (WALTON
1938). Estimates of the influence of genetic factors on birthweight vary from 70% in
one study of the singleton offspring of female twins (MAGNUS 1984) to 14% in a
study of two generations of women who delivered in the same Aberdeen hospital
(CARR-HILL 1987). Resolution of these disparate estimates depends upon whether
twin or generational studies are more successful at separating maternal and foetal
genetic factors, and environmental factors.
Kramer et al. report a study of 8719 singleton offspring from which babies with
major congenital abnormalities or infections had been excluded, and in who there
27
was good agreement between estimates of gestational age from last menstrual period
and ultrasound dating at 16-18 weeks (KRAMER 1990). Known risk factors for
growth restriction, or augmentation predicted only 17.2% of the variance in foetal
growth ratio (weight divided by predicted weight for gestational age calculated for
that population).
In summary, variation in birthweight is caused by some degree of genetic factors and
environmental factors, known and unknown.
Racialfactors
Normal values for birthweight vary between different races, babies of black ethnicity
are larger early in gestation but smaller at term (ABRAMS 1991). Moreover, data
from 1975-80 in South Carolina, showed white babies were born averaging 270g
heavier and one week later than non-white babies (ALEXANDER 1985). For low
birthweight babies, at a given birthweight or gestational age, white babies had higher
perinatal mortality. The reverse was true at higher birthweights.
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Gestational age at delivery
The mean bodyweight of the foetus increases from 500g at 24 weeks gestation
(which is approximately the most premature delivery compatible with independent
existence) to 3500g at term. This growth in overall body size is linear. (ROBERTON
1999). Premature delivery therefore strongly predicts low birthweight. 5-10% of
deliveries worldwide are premature (<37 weeks gestation). (VILLAR 1998)
Premature delivery is associated with many factors, which are listed and, where
possible, quantified below.
Geneticfactors
In a Swedish twin study, the correlation between gestational age of the singleton
offspring ofmonozygotic twins was 0.31, and 0.13 for dizygotic twin offspring. It is
not known what genes mediate this observation, the authors speculate it might be
inheritance of the risk of pre-eclampsia or cigarette smoking. (CLAUSSON 2000)
Sociodemographicfactors
Low socio-economic status is associated with premature delivery. Specific risk
factors include low maternal age (<16 years, Odds Ratio 2.91), use of illicit drugs
(O.R. 3.90), black ethnicity (O.R.2.10), exposure to trauma or surgery (O.R. 3.47),
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low rate of maternal weight gain (O.R. 1.59), short inter-pregnancy interval.(O.R.
1.77) (ABRAMS 1989).
Obstetric factors
Obstetric problems that result in premature delivery include: uterine abnormalities,
such as incompetent cervix (O.R. 6.15) (ABRAMS 1989); overdistention of the
uterus (polyhydramnios, multiple pregnancy); premature rupture of amniotic
membranes, which most commonly relates to the presence of infection; ante-partum
haemorrhage; and pregnancy induced hypertension. Previous premature labour
increases the chances of recurrence in subsequent pregnancies to 30% in a second
confinement and 60% in a third. (SYMONDS 1992)
Interventions to prevent premature delivery
Administration of P-agonist drugs can slow labour. This effect is not prolonged, but
can allow administration of dexamethasone which accelerate development of the
foetal lungs and improve the outlook if the baby is <36 weeks gestation.
(SYMONDS 1992)
An overview (VILLAR 1998) of randomised controlled trials of interventions
designed to prevent preterm birth reported efficacy of screening for and treatment of
asymptotic bacteriuria. An appropriate course of antibiotics, which may be limited to
a single dose, reduces the incidence of preterm birth by 47 % (Relative risk 0.53,
30
95% confidence interval 0.33 - 0.86). Malaria prophylaxis has not been studied in
trials with sufficient power to determine an effect. Treatment of vaginal bacteriosis is
unproven.
Nutritional supplements have insufficient evidence to support their routine use. An
old study performed in London in the 1940s suggested that fish oil supplementation
could help (THE PEOPLE'S LEAGUE OF HEALTH 1942) but no data relevant to
modern populations is available. Mineral supplements have been studied and show
promise, but better quality studies are required.
Intra uterine growth retardation
Almost all forms of pathology of mother or foetus during pregnancy are associated
with growth restriction of the offspring. Clustering ofmultiple risk factors in socio-
economically deprived populations makes dissection and quantification of individual
risk factors problematical.
Foetal abnormality
Many foetal abnormalities will result in low birthweight, e.g. chromosomal
abnormality, congenital infection, or congenital malformation. These individuals will
have many other problems specific to their condition and the incidence of these
major foetal abnormalities in populations of surviving adults is low. (ROBERTON
1999)
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Foetal exposure to toxins
Alcohol
Heavy drinking during pregnancy (3 or 4 drinks every day) is associated with the
foetal alcohol syndrome, which includes marked impairment of brain development.
Birthweight is reduced by 150g if 3 or more standard drinks are consumed. Women
who drink occasionally were shown to deliver babies 14g lighter, which may not be a
clinically significant effect.
Cigarettes
Birthweight is 100 - 250g less ifmothers smoke. (CONTER 1995) There seems to be
a dose-related effect.
Pharmacological agents
Drugs of abuse are associated with low birthweight although affluent mothers rarely
take them. (ROBERTON 1999)
P-adreno receptor blockers are widely prescribed for pregnancy induced
hypertension, and for cardiac arrhythmias in pregnancy. Growth retardation seems to
be a problem (25% of babies) if used early in pregnancy, but not if the prescription is
confined to the third trimester. (BRACKLEY 1999)
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Foetal Infection
Intrauterine infection leads to growth restriction (ROBERTON 1999).
Maternal illness
Maternal Bloodpressure in pregnancy
Disorders of blood pressure control occur in pregnancy and are a major cause of
maternal and infant morbidity and mortality. Hypertension is arbitrarily defined at
>140/90 mmHg and is divided into two categories, pre-existing hypertension
(essential hypertension) and pregnancy induced hypertension. The latter is more
ominous, encompassing a spectrum of illness from mildly raised BP in the latter
stages of the third trimester, to proteinuria (pre-eclampsia) and, with the onset of
seizures, eclampsia. Eclampsia is an obstetric emergency, complicating 1 in 2000
pregnancies in Europe. (THE ECLAMPSIA TRIAL COLLABORATIVE GROUP
1995) Birthweight is reduced because of IUGR and prematurity following expedited
delivery, which is indicated when the balance of risks to the premature foetus is
outweighed by the risk to the mother. IUGR is particularly associated with early
onset pre-eclampsia (18.2% early, vs. 5.6% in late onset). This combination is
associated with a very high perinatal mortality rate (28.7%). (LONG 1980) Another
study of 17,000 consecutive births found shortened gestational age and lower
birthweight in offspring whose gestation had been complicated by pre-eclampsia.
(HIMMELMANN 1996)
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Women with chronic hypertension are at increased risk of pre-eclampsia (for women
with diastolic BP > 110 mmHg, Odds ratio 5.2, C.I. 1.5 to 17.2). In the absence of
superimposed pre-eclampsia their risk of delivering a baby below the tenth centile is
approximately double the general population 10.9% vs. 4.1%. (MCCOWAN 1996)
Systemic illness
Women with significant medical disorders e.g. renal disease, heart disease, tend to
deliver lower birthweight babies. (ROBERTON 1999)
High altitude
Babies born in Colorado or Bolivia are smaller than those born at sea level.
(ROBERTON 1999)
Maternal Nutrition
Impaired maternal nutrition undoubtedly lowers birthweight. Studies of birth records
of babies exposed to famine in utero during World War II show a reduction of
birthweight. These populations had been reasonably well nourished before the tides
of war turned against them, and relief of famine could be precisely dated to
liberation. In Amsterdam the reduction was 200-300g. (RAVELLI 1998) During the
siege of Leningrad birthweight was reduced by 18% in boys exposed in utero and
16% in girls. (STANNER 1997)
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It is less clear the extent to which less extreme reductions in nutrition alter
birthweight, and the extent to which it is possible to alter the effect of generations of
poor nutrition. Studies of nutritional supplementation suggest that at most lOOg may
be added to birthweight by energy supplementation for expectant mothers.
(GULMEZOGLU 1997)
Socio-economic status
The effects of socio-economic status on birthweight are complex. Individuals in the
1958 birth cohort study who weighed less than 61b were more likely to experience
deprivation throughout childhood. (BARTLEY 1994) A more recent, prospective
study of pregnant women showed that the effect of social factors on intrauterine
growth were explained by maternal smoking, (BROOKE 1989) although premature
delivery was predicted by indices of social deprivation. (PEACOCK 1995)
Multiple births
Multiple births are reliably both premature and growth restricted.
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Symmetrical vs. Asymmetrical growth retardation
It has been suggested that intrauterine growth restriction may result in either
proportional, limited growth of all body parts, to babies with sparing of head
circumference and body length. Symmetrical IUGR was thought to imply more
severe and prolonged insult from factors present throughout intrauterine life.
Disproportionate restriction would result from impaired growth during the third
trimester only. This theory forms the basis for the hypothesis that foetal
undernutrition at specific crucial windows of development will result in
programming of diseases specific to that window (BARKER 1995).
It has also been suggested that different patterns of growth restriction have different
prognostic significance, although contradictory studies suggesting either pattern is
the more dangerous have been published. (CHARD 1993)
In their study of 8719 singleton offspring, (KRAMER 1990) Kramer et al
demonstrated that disproportionate growth, calculated by z scores for 5 indices of
proportion, occurred as a direct function of the severity of growth restriction. Babies
with severe growth restriction were disproportionate, but no maternal features
predicted disproportionality, over and above their effects on growth. Moreover,
disproportionate growth did not predict perinatal mortality and morbidity, other than
as a proxy for growth restriction. (KRAMER 1990)
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Interventions to prevent IUGR
" You canny make a small baby big, and you canny make a big baby small."
(THOMPSON 1998) Consultant Obstetrician, St. Johns Hospital. Livingston
An overview of 126 randomised control trials evaluating 36 interventions
commented on disparity between the quality of epidemiological trials describing the
problem of IUGR, and the trials describing treatment strategies. Many of the studies
reviewed were too small to be rigorous evaluations of the intervention under study.
Most of them did not have power to assess the key outcome of perinatal mortality.
(GULMEZOGLU 1997)
Strategies to stop smoking have been shown to increase birthweight, with greatest
success in compliant populations. Nutritional supplementation strategies have
involved various dietary manipulations. Energy supplementation may increase
birthweight by up to lOOg, especially in developing countries. Supplementation of
minerals or vitamins has not demonstrated consistent effects. Management of
hypertensive disorders in pregnancy have routinely included admission and bedrest
for which there is no evidence of benefit. Treatment with antihypertensive agents
does not reduce the risk of IUGR, and P- blocker treatment seems to increase this
risk. (BUTTERS 1990 , RUBIN 1983)
Abdominal decompression by intermittent negative pressure was popular in the
1960s but seems to have fallen from clinical practice. It was claimed that it would
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improve the IQ of babies undergoing this treatment in-utero. No such effect was
demonstrated, although children who had undergone the intervention were noted to
be "undisciplined and aggressive", perhaps as a result of their parents' perception of
their superior intelligence (HOFMEYR 1990). Two randomised trials were
performed in pregnancies at high risk of IUGR, which demonstrated a large
treatment effect (odds ratio for developing IUGR 0.21 (0.12 - 0.34) (HOFMEYR
1990). Antimalarial prophylaxis is likely to be beneficial although the optimal agent
is not known.
Summary of influences on birthweight
Birthweight is the sum of many influences on intrauterine growth and gestational
length. Reflecting the complexity of these influences, at present there are no reliable
interventions that substantially increase size at birth and reduce perinatal, and
perhaps adult cardiovascular, morbidity and mortality.
Influences on Growth: Childhood
Post-natal growth diminishes in velocity from birth during the first year of life.
Weight is lost during the first days of post-natal life as final functional maturation of
gut function is delayed. Fluid losses during this time can total 10% of body weight.
Once feeding patterns have been established in the healthy child, weight gain is
steady. Birthweight is doubled by 5 months and tripled at one year. Growth to adult
size is then more linear, with increased velocity during maturation of adrenal
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androgen production and, during puberty, gonadal function. Parental size correlates
with final adult size attained.
Deviation from a normal growth pattern is the hallmark of significant childhood
illness. Growth may be postponed, and convalescence may be characterised by
"catch-up" growth, but some individuals remain stunted and never fulfil their
potential, genetic height. Socio-economic deprivation and particularly malnutrition
are powerful inhibitors of childhood growth.
Potential mediators of birthweight: blood pressure association
Having considered the numerous influences upon birthweight that exist, the question
arises as to which may influence subsequent blood pressure. The causes of essential
hypertension remain obscure, although hypotheses include activation of the
sympathetic nervous system, or excessive dietary intake of sodium. It is inevitable
that associations between measurements made at remote time points may be




High blood pressure is a familial trait (WATT 1991), and offspring of pregnant
women tend to have low birthweight as discussed above. There is also evidence to
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suggest that mothers who have had higher blood pressure measured during, or
remote from, pregnancy, have offspring with higher blood pressure.
The Hypertension in Pregnancy Offspring Study followed up a cohort of 36
individuals whose mothers had had blood pressure >140/90mmHg during pregnancy.
In these children gestation was shorter than 17 controls (38.2 weeks vs. 40.2,
p<0.01), birthweight lower (3235 g vs 3655, p<0.05), and systolic blood pressure
recorded at the age of 7-12 years, was higher (120 mmHg vs 112, p<0.01).
(HIMMELMANN 1994)
The influence of parental blood pressure was examined in a study of 452 young
adults whose parents had been screened for inclusion in the MRC mild hypertension
trial. Maternal (but not paternal) blood pressure measured approximately 10 years
after their pregnancy was shown to confound the relationship between birthweight
and blood pressure in their offspring. (WALKER 1998) In this study, 24% of the
association was explained by inherited factors, which may be genetic, or shared
familial environment.
Early studies did not find maternal BP during pregnancy confounded the associations
with later offspring blood pressure. Martyn et al. demonstrated that higher maternal
blood pressure measured during pregnancy was associated with higher adult blood
pressure, independently of the effect of birthweight on adult BP. (MARTYN 1995)
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A paper studying the influence of maternal factors on blood pressure in 4 year old
children showed that a relationship persisted between birthweight and current blood
pressure when adjusted for maternal blood pressure measured 4 years after
pregnancy, although no significance tests are quoted. (LAW 1991) The paper also
does not mention whether maternal BP measured either during pregnancy or later
influenced birthweight.
A study of 3591 school children showed that a history of maternal hypertension
predicted current BP but did not confound the association between birthweight and
BP. The paper does not show whether maternal hypertension predicted birthweight.
(WHINCUP 1989)
It is acknowledged that blood pressure recordings during pregnancy may be less
accurate. (SHENNAN 1996) Churchill et al. (CHURCHILL 1997) recorded
ambulatory blood pressure monitoring during pregnancy in 209 nulliparous women
demonstrating associations between 24 hour mean diastolic BP at 28 weeks and
weight at term. A 5 mmHg increase in BP was associated with a 107 g decrease in
weight at term and independently, a 2.3 day decrease in gestational age at birth.
Women with pre-existing hypertension and women who developed pre-eclampsia
were excluded from this study.
In summary, higher maternal blood pressure predicts offspring with lower
birthweight and subsequent higher blood pressure. Acknowledging that it is difficult
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to obtain accurate data for two generations of adults, this is an important factor to
quantify in further, large, high-quality epidemiological studies.
Socio-economic deprivation
A 1998 overview of studies examining the influence of socio-economic status on
blood pressure suggested that a difference of 2-3mmHg of systolic blood pressure
(COLHOUN 1998). The influence was strongest in women and related to obesity.
Differences in treatment rates did not seem to account for this effect, although were
not examined in most of the studies.
As discussed above, low socio-economic status is a strong risk factor for low
birthweight as a result of both prematurity and growth retardation. While many
studies have attempted to allow for this source of confounding, the multiple,
pervasive influences of socio-economic deprivation are difficult to fully quantify,
and to make valid statistical adjustments to the relationships in question (JOSEPH
1996).
Some studies have not had information on social class in the available data
(BARKER 1989 BMJ, LAW 1993). Others have assessed current social class but not
examined for confounding of the relationship between birthweight and blood
pressure, (LAW 1991) or the outcome measured e.g. arterial compliance (MARTYN
1995). These adjustments may be insufficiently subtle as errors in attribution of
social class may disproportionately alter the results, and differences in other indices
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of deprivation may be greater within social classes, than between classes. (JOSEPH
1996)
Potential mediators of birthweight: blood pressure association
Intra-uterine Programming?
Nutrition: "The Barker Hypothesis"
Professor Barker from Southampton has been extremely active in producing
epidemiological studies. He has proposed a detailed theory describing developmental
windows in which specific disease processes are programmed by nutritional
deprivation at crucial times in development. This arises, at least in part, to explain
associations between adult outcomes and measurements of proportionality. This is
acknowledged by him to be a work in progress (BARKER 1995). The contradictions
in the results of studies that look at these relationships (HUXLEY 2000, JOSEPH
1996) makes this hard to sustain, and more recent work from Southampton has been
emphasised the role of postnatal growth. Although considerable emphasis is given to
maternal nutrition as a potential cause of low birthweight and subsequent raised
offspring blood pressure, little consistent data support this assertion.
Researchers contacted offspring of women who had participated in a survey of diet
during pregnancy in 1948 - 1954 (CAMPBELL 1996). Lower birthweight predicted
higher adult blood pressure (4.8 mmHg / kg, p=0.01), but placental weight did not
(9.2 mmHg per kg placental weight, p=0.2). No index of maternal dietary
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constituents predicted birthweight. After division of the study into two groups
according to animal protein intakes of greater than or less than 50g per day,
statistically significant associations between carbohydrate intake and placental
weights and between carbohydrate intake and adult blood pressure emerged. At low
animal protein intakes higher carbohydrate intake predicted higher blood pressure
and lower placental weight. The converse was true at high intakes of animal protein.
Other investigators contacted 77 children born to women who had participated in a
study of haemoglobin concentrations and of weight gain and skinfold thickness in
pregnancy (GODFREY 1994). In this study decreased maternal triceps skinfold
thickness predicted higher offspring systolic blood pressure (10.7 mmHg per log mm
decrease in skinfold thickness, p=0.0001). There was also a relationship between
maternal haemoglobin and offspring blood pressure, although this was abolished by
the relationship with triceps skinfold thickness in multiple regression. Low maternal
weight gain between weeks 15 and 35 of gestation was also associated with higher
blood pressure in offspring (-0.6 mmHg per kg gained, p=0.02).
Maternal haematological status and childhood blood pressure were studied by
Whincup et al in 1311 children age 9-11 years (WHINCUP 1994). Low haemoglobin
concentrations, and change in mean corpuscular volume did not predict blood
pressure, although they did predict lower birthweight. The authors comment that
changes in haematological indices in pregnancy is a complex area with an uncertain
relationship with foetal and maternal nutrition.
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Two studies have reported blood pressure in adults exposed to famine in utero.
(ROSEBOOM 1999, STANNER 1997) (see nutrition and IUGR above). Neither
showed a significant difference in blood pressure in exposed infants compared to
non-exposed.
Postnatal diet
Alan Lucas and colleagues randomised 758 children with low birth weight (<1850g)
to 4 different diets which contained very different compositions of nutrients, and
recorded blood pressure at follow up at 7.5-8 years of age. No component of diet, nor
pattern of postnatal growth predicted blood pressure (LUCAS 1994). Further follow
up of the cohort showed lower blood pressure in the group randomised to pooled
breast milk (SINGFIAL 2001A) (Mean arterial pressure 81.9 mmHg vs. 86.1 mmHg,
p=0.006). These researchers are exploring what aspect of early nutrition might
mediate influences on blood pressure (SINGHAL 200IB). Although sodium intake
has been implicated in an animal model of early feeding (GOULDSBOROUGH
1998), this may not be the case in humans.
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Twins
One implication of the programming hypothesis is that higher blood pressure should
be particularly prevalent in twins, as they are inevitably growth restricted during the
third trimester, but this is not the case. In a prospectively studied birth cohort in
Dunedin, twins had lower blood pressure than singleton children at the ages of 9 and
18. (WILLIAMS 1999)
Within twin pair birthweight differences showed correlations with differences in
adult blood pressure in a study of 492 female twin pairs studied in London
(POULTER 1999). The regression coefficient was 5.8 mmHg for every kg difference
in birthweight. Similarly, a study of 8 year old twin pairs in Tasmania (DWYER
1999), within twin pair weight difference was inversely associated with BP (-5.3
mmHg per kg birthweight. In these studies similar trends were seen if only
monozygotic twins were included in the analysis, although limited numbers meant
that these analyses did not reach statistical significance. Izjerman et al. report
significant in pair correlations for dizygotic but not monozygotic twins (IZJERMAN
2000). However, no between twin differences were seen in a much larger study of
8000 female Australian twin pairs. (NOWSON 2000)
Smoking
This factor has been controlled for in some studies (LEY 1997, WHINCUP 1992)
and not demonstrated to influence the association between birthweight and blood
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pressure, but information is not available for many studies (HIMMELMANN 1993,
LAW 1991, LAW 1993, LEON 2000, VALDEZ 1994, WHINCUP 1989). A study of
795 members of a New Zealand cohort demonstrated that systolic blood pressure
was 1.54 mmHg higher in individuals whose mothers had smoked during the
pregnancy (WILLIAMS 1999). As maternal smoking is a potent and potentially
avoidable, factor influencing it is an important unresolved issue to be considered in
more detailed epidemiological studies.
Gestational age
The "Barker hypothesis" does not include a role for premature delivery in the
mediation of the observed effect (BARKER 1998). This assessment is based on the
lack of an association with gestational age in many of the previously published
studies. The data chapters that follow will challenge this interpretation, so this point
is considered in some detail.
The largest study of the association between birthweight and blood pressure
examined the birth records and records of medical examinations performed for
conscription into the Swedish armed forces (LEON 2000). Records for 165,135
eighteen year old men were complete, which comprised 78% of singleton male births
(1973 - 1975). This study showed that systolic BP increased by 1.47 mmHg per kg
birthweight (after adjustment for adult size) and an independent decrease of
0.25mmHg per completed week gestation. Babies born earlier than 35 weeks were
excluded because of evidence of inaccurate gestational age assessments.
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In a study of 430 Swedish men with mean age 49 years, there was no relationship
between birthweight and blood pressure, but a weak relationship between gestational
age and blood pressure was shown for the entire cohort (r = -0.10, P =0.04; n = 430).
A stronger association between systolic blood pressure and gestation was shown
when premature (<38 weeks gestation) babies were considered alone (r= -0.46, P
=0.001). The relationship was particularly strong for low birthweight (<2.5kg)
babies, (r= -0.86, p<0.001; n = 14) although this is a very small subgroup of the
population. (SIEWERT-DELLE 1998)
Several papers by Whincup and colleagues have shown similar results in children. In
3 year old children, (n=1860) systolic blood pressure decreased by 0.37 mmHg per
completed week of gestation (WHINCUP 1999), although this was not independent
of birthweight (adjusted regression co-efficient 0.13 mmHg, p=0.34). A similar
result was demonstrated in 3360 children selected from towns with widely
contrasting cardiovascular mortality rates. (WHINCUP 1992) Information on birth
information was collected by questionnaire. This study included children with
gestational ages from 28 to 44 weeks. After adjustment for current size lower
birthweight predicted higher systolic blood pressure (regression coefficient 2.05
mmHg per kg), as did premature delivery (0.35 mmHg decrease in systolic blood
pressure per completed week, However simultaneous adjustment for birthweight and
blood pressure abolished the association with gestational age (adjusted 0.06, p=0.57).
The authors note that gestational age is less likely to be accurately recalled, and the
stronger association with birthweight may reflect greater precision in measurement.
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In a third study (TAYLOR 1997) of 8 -11 year old children similar associations
were found between birthweight and blood pressure for preterm, (-1.16 mmHg per
kg, p=0.07), and term infants (-1.39 mmHg / kg, p=0.0005).
Reasons for lack ofobserved effect ofgestational age at birth
In the 80 studies reviewed by Huxley et ai, 58 did not have information on
gestational age (HUXLEY 2000). 16 studies did not demonstrate a relationship
between gestational age and birthweight. They are examined in the table. Gestational
age, as has been noted above, tends to be inaccurately assessed, especially before
ultrasound was available, and is frequently rounded to completed weeks of gestation,
which introduces further inaccuracy. Many studies recruited only babies born around
term, which may be in part due to the poor prognosis of premature babies born
before modern neonatal care.
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FirstauthorNumberAginyearsGestationalgadj s m ntre ultotes meanS.D. Hashimoto1953.80 18.6simpleregressionnoeff cg stati nd dtpred ty t l c(r=0 03,p=0.72)or (HASHIMOTO1996)diastolic(r=0.12,p=0.10)bloodressure. Woelk7566.50.63notstatedN S.tertil sfgestationeff c<38week91,98mmHgag ins89.89 mHfor8- (WOELK1998)(N.S.)3weeks,89.93mmHgfor40to4e ks.N statisticalte tiquo ed Yiu29587.10 23 .7multipleregressionnoeff ctadjustedBmHg/w ek-0.08,p=0.5 (YIU1999) Barker992110N.S.SimploeffectIllustrat d,nstatisti alt tquoted (BARKER1989)regression Forrester16106-16-38.87.92multiplreg s ionNoff ct1409wereb nate m,et e nnd42weeks' (FORRESTER1996)(rangegestation Ley6890.737.92multipleregr ssionnotshown (LEY1997)
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Himmelmann (HIMMELMANN 1994) Zureik (ZUREIK1996) Matthes (MATHES1994) Leger (LEGER1997) Campbell (CAMPBELL1996) JieMi (MI2000) Barker (BARKER1990) Martyn( ARTYN
5312.5 21013.2 33015.7 51620. 253-40 62745 4496-5 (range) 33750-




1.8simpleregressionNoffect=-0.12,pn ti nifican N.S.multipleregressionnotsh wn N.S.multipleregressionp=0.66Casecon rolst dy,lowra gfbirthwei ht 1.2simpleregressionnoth wnOnly>37we ks,ith rbirthweightorg station predictedBP 1.84multipleregressionnotsh w 2multipleregressionnotsh w N.S.multipleregressionnoeff ct 2multipleregressionnotsh wn
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1995) Roseboom (ROSEBOOM1999) Thame (THAME2000) Alves (ALVES1999)
73950.4 4281-3.5 (range) 63412-36hours (range)
0.9
40.91.7multipleregressionnotsh wn 39.41.86MultipleregressionNotshown 39.3N.S.MultipleregressionotshownExcluded<37we ks,APGARsc r s7
Table1 Thistableshowsemainfeaturofths diatdnoninfluencege tati nalgos b equentblpressur .B pressurewashigheinprem turendividu lthst dyofW lketal.ltho ght iwaa ar ntlnstat sticallsignificant. Thesestudiestendobsmall rt antudiesth thavsh wneff ctsfrog st on,um sts emthavexplicitlyc n id red thepossibilityandmadea propriateadjustments,alth ughtheresultsofestrnalwayquotifu l.
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Potential mediators of birthweight blood pressure association:
Endocrine systems
In this introduction, the evidence considered has consisted of epidemiological
studies, demonstrating a consistent association between birthweight and blood
pressure, and less consistent associations between aspects of life during pregnancy
for mother and foetus, and subsequent blood pressure. This section will consider
potential hormonal mediators which might link early life to cardiovascular disease.
The next section will outline a theoretical basis supporting altered vascular structure
as a programming mechanism.
Foetal Insulin theory
Insulin is an important growth factor during intrauterine life. Hattersley and Tooke
(HATTERSLEY 1999) have suggested that lifelong insulin resistance could explain
associations between birthweight and blood pressure. Insulin is an important
mediator of foetal growth, therefore insulin resistance would impair intrauterine
growth. The adult would remain insulin resistant and display the phenotype of
glucose intolerance and elevated blood pressure. Mechanisms that may explain the
link between insulin resistance and hypertension are explored in chapter 5. Their
theory is supported by studies of babies with single gene disorders of insulin
metabolism. Low birthweight is a feature of these illnesses. This theory explains the
associations without invoking programming.
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Placental steroid metabolism
A different hypothesis was also published in The Lancet (EDWARDS 1993). In rats,
decreased activity of the placental enzyme that protects the foetus from exposure to
maternal glucocorticoids (11-13 hydroxysteroid dehydrogenase type 2) is associated
with decreased birthweight. Moreover, administration of dexamethasone to pregnant
rats results in reduced birthweight, and higher blood pressure in their offspring. The
authors suggest that increased foetal exposure to glucocorticoids may permanently
alter metabolic control, with resulting hypertension and insulin resistance.
Hypothalamic Pituitary Adrenal Axis abnormalities
Abnormalities of glucocorticoid metabolism have been demonstrated in numerous
cohort studies. Early morning fasting plasma Cortisol concentrations were increased
in iow birthweight members of cohorts from Adelaide, Preston and Elertfordshire
(PHILLIPS 2000). A more detailed study of 370 men from the Hertfordshire cohort
demonstrated associations between their fasting Cortisol concentrations and features
of insulin resistance (PHILLIPS 1998). In a further study of the Hertfordshire cohort,
205 men had overnight suppression of endogenous glucocorticoid production
following oral dexamethasone (REYNOLDS 2001). Their response to intravenous
ACTH was then measured, and was greatest in the low birthweight individuals.
Thus, there is evidence that it is possible to programme the Hypothalamic Pituitary
Adrenal Axis, and evidence of abnormalities of the functioning of components of the
54
axis in adult males with low birthweight. It might be that different influences on
birthweight have similar, long lasting effects upon the functioning of the
Hypothalamic Pituitary Adrenal Axis, and subsequent higher blood pressure.
Potential mediators of birthweight: blood pressure association:
Vascular Structure
The vascular tree is a supremely efficient mechanical system. It takes a lifetime for
the subtle increase in work required of the vasculature in hypertension to manifest
itself in the catastrophic events of stroke or myocardial infarction. This section will
discuss the changes that are present in vascular and cardiac structure in many
patients with hypertension. These changes are important in the altered
haemodynamics in hypertension, and have prognostic significance. This leads to the
hypothesis that altered vascular structure could be programmed by early
development, which would in turn, programme the development of increased blood
pressure.
Increased peripheral resistance with a normal cardiac output is the hallmark of
hypertension. Resistance varies throughout the vascular tree and vessels of less than
500 micrometers in diameter form the greatest component (BORDERS 1986,
STRUIJKER BOUDIER 1992). Abnormalities of these vessels have been described
in human skin (PRASAD 1995), muscle (HENRICH 1988, PEDRINELLI 1990),
conjunctival (HARPER 1978), retinal (STANTON 1995) and gut vasculature
(SHORT 1958) in hypertension and can be shown to increase resistance (FOLKOW
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1995). However, in the presence of normal renal function, the effect on blood
pressure from increased peripheral resistance would be cancelled out by pressure
natriuresis. (GUYTON 1972) In other words, over a remarkably wide range of blood
pressure, any rise in pressure is followed by increased sodium excretion which
restores the original blood pressure. Transplantation experiments performed in
immunologically compatible rats, between hypertensive and normotensive
individuals show that the transplanted kidney dictates the blood pressure of the
recipient (BIANCHI 1974, DAHL 1975). A series of patients with endstage renal
failure as a result of severe hypertension who had therapeutic renal transplantation
gained remission from hypertensive disease maintained over five years (CURTIS
1983). This study preceded routine cyclosporin use which confers hypertension upon
most recipients. Therefore if increased peripheral vascular resistance is a primary
change in hypertension, factors involved in the generation and maintenance of
increased vascular resistance must be considered for both renal and non renal
vasculature.
Structural changes in peripheral vessels
The vasculature of an individual with established hypertension has several
distortions from normal. Vessel walls are thickened in the small arteries and
resistance arterioles, and vessels are diminished in number or rarefied. These
changes have been described for more than one hundred years.
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Thickening of vessel walls with consequent increase in wall to lumen ratio is termed
hypertrophy. The methods used to investigate this change in humans have been
reviewed by Schiffrin (SCHIFFRIN 1997). The term implies growth and division of
wall components but this may be misleading. Baumbach and Heistad (BAUMBACH
1989) were first to suggest that it is remodelling of existing vessel components that
results in the thicker wall. They demonstrated this in cerebral arteries of Stroke prone
Spontaneously Hypertensive Rats (SpSHR). Work reviewed by Heagerty et al
(HEAGERTY 1993) has shown that in most studies this is the dominant effect in
essential hypertensive patients and in Spontaneously Hypertensive Rats (SHR).
Growth and cell division contribute much less.
Rarefaction refers to reduced vessel number per volume of tissue. This phenomenon
has been demonstrated in multiple tissues in humans and rats. Short described
arteriolar rarefaction in hypertensive cadavers in the 1950s (SHORT 1958, SHORT
1966); in vivo rarefaction has been demonstrated in conjunctivae (HARPER 1978),
skeletal muscle (HENRICH 1988) and nail beds (GASSER 1992) in hypertension.
This may be a response to local pressure in the studied network and a functional state
may precede anatomical changes. SHR have diminished arteriolar numbers which
can be overcome by high dose vasodilators in young animals but not in older animals
(HASHIMOTO 1987). However, this interpretation is challenged by data from
experiments inducing hypertension by coarctation (BOEGEHOLD 1991). The
hindquarters of the animal are not exposed to the elevated systemic pressure but
nevertheless rarefaction occurs. The cellular mechanism involved in development of
rarefaction may well involve apoptosis. Electron micrographic studies demonstrated
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cellular markers of apoptosis (GOBE 1997) in endothelial tissues in Goldblatt
hypertensive rats (one kidney, one clip).
Left Ventricular Hypertrophy
Thickening of the left ventricle is an important feature of hypertension as it is
associated with higher risk of death (LEVY 1990). Left ventricular hypertrophy
(LVH) can be detected by electrocardiography, or more accurately by ultrasound or
magnetic resonance imaging (KANNEL 1998). The prevalence of LVH increases
with age, systolic blood pressure and obesity (LEVY 1988), and the prognostic
implication remains when these, and other cardiovascular risk factors are controlled
for in multiple regression analysis. Although population derived cut off points are
often used in studies, there is a linear association with risk of death at all levels of
LV Mass. A 50g increase in LV Mass predicts a 1.49 increase in relative risk of
death (LEVY 1990). The processes involved in the development of LVH are
discussed later.
Haemodynamic effect of structural vascular changes
The key experiments that first illustrated the functional significance of these changes
were performed by Bjorn Folkow in Sweden in the 1950s. Prior to this, decreases in
the minimum vascular resistance of tissues had been described in hypertensive
patients with plethysmography (PICKERING 1950). Folkow showed for the first
time (FOLKOW 1958) that the relationship between minimum vascular resistance
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and pressor responses to noradrenaline was identical in hypertensives and
normotensives. He inferred that for any given pressor tone, resistance from
hypertensive vessels will be greater as a result of the increased luminal
encroachment by the thickened wall. Thus, the structural change in the vessel wall is
translated into the functional change of increased resistance without requiring
alterations in smooth muscle activity or pharmacological sensitivity to vasoactive
agents.
The "Structural Factor" Folkow described is a generally accepted principle in
hypertension. The relative significance of rarefaction arouses more controversy.
Hallback et al (HALLBACK 1976) simulated rarefaction in the hindquarters of a rat
by injection of microspheres. These were 50 pm in diameter and blocked 50% of
microvessels of that size. No enhancement of the effect of vasoconstrictors was
observed and he concluded that rarefaction did not significantly increase resistance.
However, a mathematical model study by Greene et al (GREENE 1989)
demonstrated that rarefaction of 42% of 3rd or 4th order vessels would lead to 21%
increased resistance. This model was based on the hamster cheek pouch which forms
an idealised branching structure. This may have different characteristics to vascular
beds which contribute more to peripheral resistance. Modelling techniques are not
yet sufficiently advanced to describe interactions between hypertrophied vessels and
rarefied networks. It has been suggested that vessel remodelling proximally and
distal rarefaction will act in a synergistic manner (ZWEIFACH 1983) and the
combination will lead to greater resistance than the simple product of each
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component. Sophisticated modelling may be the path for future research to establish
the relative importance of observed changes in different vessels.
Changes in the renal vessels
The cardinal histological change seen in hypertensive kidneys is narrowing of the
afferent arteriole. The classic studies by Sommers (SOMMERS 1958) identified a
spectrum of disorder throughout 1800 renal biopsies. This varied from focal spasm
of arterioles with concentric overlapping of smooth muscle in the mildest cases to
more severe changes with endothelial oedema leading to luminal encroachment,
smooth muscle hypertrophy, degenerative changes with hyalinisation and irregular
and focal luminal narrowing. Traditionally these changes were thought to develop
after some years of established hypertension (CASTLEMAN 1948) A recent study
examined renal tissue from young adults who died traumatically and demonstrated a
correlation between arteriolar narrowing with increasing incidence of hypertension in
their country of origin (TRACY 1992).
These changes are not uniformly distributed through the kidney and will lead to
relative ischaemia in the more severely effected nephrons. Sealey (SEALEY 1988) et
al have proposed that the renin secreted by the ischaemic nephrons will have a
disproportionate effect on blood pressure. The majority of normal nephrons will
ensure adequate renal function, and increases in blood pressure will tend to lead to
correction through sodium natriuresis. However, this response will be incomplete
due to the promotion of sodium retention though angiotensin II from the ischaemic
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nephron population. This phenomenon may explain in the variation between an
individual's responses to sodium loading, and the residual circulating renin in some
hypertensive patients when renin should be suppressed by increased perfusion
pressure.
The origins of vascular structural changes: Developmental Relics or
Compensatory Plasticity?
So far this section has described structural changes which have been reported and
commented on the haemodynamic alterations which result. We have shown that
vascular structure can influence renal function, peripheral vascular resistance and
hence blood pressure. Could they be a programming mechanism linking events in
early development with higher blood pressure?
Hypertrophy and rarefaction are maladaptive changes in view of the demonstrable
decrease in mechanical efficiency that they cause and the vascular catastrophes that
they predate, but they result from the same developmental principles that create
efficient structures with minimal mechanical work. Control of vessel growth and
development is determined by nutritive demands from the dependant tissues
(ADAIR 1990). Feedback from the resulting flow in the form of shear stress and wall
stress alters growth and development of cellular wall components. These processes
determine embryonic development of a vascular tree and subsequent remodelling to
the changing demands of the growing organism. This plasticity of vascular structure
is retained in the mature adult and can be demonstrated in animal models.
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The interaction between the ability of structures to remodel towards the ideal for
their function, and the limits imposed by the other components of the cardiovascular
system can be illustrated by the following example. Wall remodelling has been
shown mathematically to reduce tension in the vessel wall when it is exposed to
increased pressure (ZWEIFACH 1983) and is thus adaptive to the circumstances of
that vessel. However remodelling results in luminal encroachment and increased
resistance which increases the pressure loading on the system, and is maladaptive.
This also illustrates the central idea of programming; adaptive responses to
circumstances early in life may become maladaptive for the adult organism.
We suggest that structural changes may be present at an early stage of development
as a result of relative increases in flow and pressure during intra-uterine life in the
low birthweight baby. These changes, or an increased capacity to develop these
changes, may persist and manifest themselves in adult life as hypertension. To
support our hypothesis, we will describe normal vascular development, animal
experiments demonstrating retained adult plasticity, and human studies showing
altered vascular structure early in the development of hypertension.
Vascular Embryology
Vascular cells derive from mesoderm, differentiating into blood cellular components
and vessel components before flow is established. Growth of vessel walls is initially
controlled by VEGF primarily leading to differentiation and division. As marshes of
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blood vessel components stir into flowing channels, tissue demands mediated
through oxygen and adenosine as paracrine factors will stimulate further growth
(RISAU 1997). A combination of vessel wall factors in response to circumferential
and shear stress will stimulate development of additional wall components and
accumulate smooth muscle cells and extra-cellular matrix including elastic fibres that
characterise arteries and arterioles. The cellular and molecular mechanisms
governing this process are beginning to be identified and are comprehensively
reviewed by Cowan and Langille (COWAN 1996). Network factors are less well
studied in vivo than cellular mechanisms. The methods by which genetic blueprints
for a vascular tree or organogenesis are translated into functioning structures are
beginning to be understood. A family of homeobox genes has been identified and
linked to tissue polarity in wing development in Drosophila (BLANKESTEIJN
1996) and myocardial repair in rats (DE ROBERTIS 1990).
Cardiac Embryology
Embryological development of the heart occurs during the early weeks of gestation.
Formation of the initial tube occurs at day 21 (SADLER 1984). This coils around
itself and initially divides into two chambers. Septa sprout from opposite poles of the
ball like heart and grow towards each other establishing the twin pumping systems of
pulmonary and systemic circulations. Ventricular growth will be stimulated by
stretching of myocytes, as the functioning vasculature responds to the demands of
the growing organism, and by sequences of gene activation, cascading in concert.
Further demands will be made on the left ventricle at birth, when the output of the
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right ventricle switches from the systemic circulation to the pulmonary circulation
with closure of the ductus arteriosus. This will lead to further growth of left ventricle
establishing adult proportions between the ventricles. Hyperplasia of myocytes
continues throughout intrauterine development, although during the final trimester
the ability ofmyocytes to divide is lost (RAKUSAN 1985) and further growth of the
muscle occurs through growth of individual cells and laying down of extacellular
matrix.
Plasticity ofmature vasculature
There are limits to the further differentiation of the mature vascular tree. Clearly it is
not possible to grow a second aorta. Animal models suggest that there is
considerable plasticity of vessels supplying muscles. Pig right ventricles hypertrophy
in response to a pulmonary artery banding (WHITE 1992). Haemodynamic studies
of the right coronary arteries in these animals demonstrated no additional resistance
compared to control arteries indicating that the increased demands of the muscle
produce an ideal, mechanically minimised network. The characteristics of the new
network are an increased ratio of arterioles to capillaries; the number of vessel
divisions from coronary ostium to capillary was found to be increased from 10 to 11.
The increased branching begins in proximal vessels indicating residual plasticity in
well differentiated structures. Tissue demands will not be the sole stimulus to vessel
growth in this model and it is possible that chronic vasodilatation and muscle
pressures may also be transduced into vascular growth.
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Another model that demonstrates adult vascular plasticity is the cremaster muscle of
rats with unilateral orchidectomy (WANG 1991). The operated side has diminished
vessel density in an identical milieu other than loss of load bearing function in the
muscle.
Mathematical modelling
Mathematical models of vascular networks support the theory that shear stress and
circumferential stress in combination as modifiers of growth can lead to idealised
flow (KIANI 1991). Alternatively with different criteria in the model the network
would remodel into a single vessel (HACKING 1996). These models are relatively
crude, limited to describing possible mechanisms to create capillary meshworks to
supply homogenous tissue metabolic demands.
Plasticity of Renal Vasculature
Irregular involvement of nephrons in pathological responses could be accentuated in
the presence of limited absolute nephron number. This theory was first outlined by
Brenner in 1988 (MACKENZIE 1995). Nephron number varies between individuals
from 300,000 to 1,100,000 (NYENGAARD 1992) and is determined at birth
(BRENNER 1985). Further renal growth is finite and limited to increasing the size of
components of the nephron. Individuals with numerically limited functional reserve
will be more susceptible to the pathological processes of high blood pressure
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described above. The supporting evidence is accumulating but is circumstantial.
Populations with different susceptibilities to salt sensitive hypertension have been
shown to have smaller average size of kidneys (LUFT 1979). Experimental renal
mass reductions increase the risk of hypertension (BRENNER 1985) as does surgical
reduction in removal of renal tumours (NOVICK 1991) or unilateral nephrectomy
for donation (HABERAL 1998).
Development of Left Ventricular Hypertrophy
Ventricular growth continues during childhood, once adult size has been determined
LV Mass is dependent upon demands. Obesity is associated with increased LV mass
(DE SIMONE 1992). Men have greater LV mass than women, but this is mostly
accounted for by increased lean body mass (DE SIMONE 1995). There is probably
no growth with advancing age in maturity, although it is very difficult to separate the
effect of age and the increasing incidence of hypertension that occurs with age.
Physically active people will have greater LV Mass than sedentary people, but when
the demands decrease, regression of hypertrophy occurs rapidly. This is in contrast to
the limited regression seen in treatment of hypertension associated LVH
(SCHMIEDER 1998).
Hypertensive Cardiopathy?
The additional growth in left ventricular size that occurs in association with
hypertension is qualitatively different from the normal growth and development
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processes, or the hypertrophy associated with athletic training. These differences
have pathophysiological implications.
Pathological hypertrophy is characterised by growth of individual myocytes, and
increase in the collagen content of extra-cellular matrix, leading to fibrosis (WEBER
1998). Increasing tissue mass is not accompanied by matched vascular growth, and
coronary reserve, the capacity of the vascular bed to accommodate increased flow, is
decreased (SCHWARTZKOPFF 1998). These changes lead to increased ventricular
stiffness and therefore increased myocardial oxygen demands. Tissue ischaemia
promotes further fibrosis, cardiac arrhythmias, and eventual heart failure.
LVH and prediction of subsequent blood pressure
Increased left ventricular mass predicts individuals who will go on to develop the
greatest rise in blood pressure in follow up studies. (DEVEREUX 1991) This has
been found in the Framingham study (POST 1994), in a population of employed
adults of average age 47 (DE SIMONE 1991),a population ofmiddle aged Japanese
men (ISO 1994) and in children aged 6-15 years (MAHONEY 1988). This is in
contrast to other haemodynamic variables which do not predict risk of hypertension
independent of stature (POST 1994).
It seems plausible that the development of higher blood pressure, and left ventricular
hypertrophy develop in parallel. This is predicted by the theory proposed by Lever
and Harrap (LEVER 1992) that the central abnormality in hypertension is of
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mismatch of blood pressure rise and somatic growth in childhood. It may be that
common hormonal and growth factors are involved in both processes.
Vascular Structural Changes in early Hypertension
Evidence supporting programming of vascular structure as an important process in
the development of hypertension comes from studies showing structural changes
early in the process, especially in people with a familial tendency to develop
hypertension. Japanese subjects with a strong family history of hypertension have
diminished reactive hyperaemic forearm blood flow (TAKESHITA 1982). Subjects
with early essential hypertension characterised by higher cardiac output had capillary
rarefaction demonstrated in conjunctival micrographs (SULLIVAN 1983).
Familial determinants of blood pressure have been studied through a novel
epidemiological method. The population attending a single medical centre at
Ladywell in Edinburgh had their blood pressure screened. By studying groups of
offspring defined by a function of their own and their parents' blood pressure, factors
associating with their familial tendency to develop high blood pressure can be
separated from factors consequent upon their blood pressure. Non invasive studies of
microvascular blood flow demonstrated abnormalities in the offspring who shared
above average blood pressure with their parents (NOON 1997). They had 50% lower
maximal blood flow in heated skin and diminished capillary number following
venous occlusion. These abnormalities are of the magnitude observed in established
hypertension but the differences in blood pressure between the subject groups were
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small (6 mmHg). Thus abnormalities in the microvasculature are present prior to a
rise in pressure, and not present in everyone with a higher pressure suggesting a
possible causative role in the inherited rise in blood pressure.
These changes will tend to increase blood flow in the fewer vessels, which we know
from the animal studies will provide the stimulus to develop more vessels to correct
the mismatch between growth and flow. Yet the abnormalities persist. This might be
due to decreased sensitivity to the stimulus of increased flow or to the growth
message transduced by that flow. Alternatively the peripheral microvessel structures
may be an appropriate response to the pressure set by the kidney which may have
fewer nephrons or populations of ischaemic nephrons influencing the pressure
natriuresis relationship.
Whatever the precise mechanism we can appreciate that these subtle maladaptions
can develop, persist and feedback to increase peripheral resistance. Adaptive
structural alterations from the ideal may be beneficial during times of rapid growth
and development, or protective during nutritional insufficiency but burden the
organism with the structural basis for subsequent high blood pressure and increased
risk of premature death.
Microvascular structure and function, and Insulin resistance
In addition to the effects on peripheral vascular resistance that have been discussed,
it has been postulated that altered microvascular structure could also contribute to
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insulin resistance, by limiting the rate of glucose delivery and therefore insulin-
mediated glucose uptake (LILLIOJA 1987). Normotensive individuals with fasting
hyperglycaemia have a decreased skin hyperaemic response which is associated with
a higher fasting insulin concentration (JAAP 1997) Moreover, glucose uptake may
be enhanced by insulin-mediated vasodilatation, which is largely dependent upon
nitric oxide synthesis (BARON 1995). Insulin resistance is associated with high
blood pressure in many patients with hypertension (FERRANNINI 1987) and also
those at risk of hypertension (HULTHEN 1995), although the mechanism is
unknown.
This review has focussed on vascular structural abnormalities present in
hypertension and in individuals at risk of hypertension. Blood vessel function is also
altered in hypertension (PANZA 1990) and in individuals at risk (TADDEI 1992),
demonstrated by impaired vascular responses to the endothelium dependant
vasodilator acetylcholine.
Endothelial dysfunction may therefore contribute both to insulin resistance and
hypertension. These observations raise the possibility that diversity of vascular
function or structure contributes to the variance of both insulin sensitivity and blood
pressure in health. It also follows that programming of vascular structure or function
could mediate insulin resistance in addition to higher blood pressure.
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Summary of introduction, and statement of hypotheses
To summarise the introductory chapter, low birthweight predicts a range of
cardiovascular risk factors in later life. This may or may not represent a causative
relationship. If it is causative, and "programming" has occurred this may have been
during intra-uterine life, or during postnatal development. Furthermore, it has not
been established what systems are susceptible to programming in humans, and we
have outlined a rationale for programming of vascular structure.
Many of the studies describing this area are retrospective analyses of fortuitously
preserved records. The relationship between low birthweight and high blood pressure
is robust, but there are several issues which have not been clarified:
• What is the effect of length of gestation?
• What is the role of confounding from maternal factors and from socio-economic
deprivation?
• What is the role of catch up growth?
• What is the role of infant nutrition?
These questions are considered in the study described in the next chapter, which
investigates associations between adult cardiovascular risk factors and observations
made in a prospectively recruited cohort of low and normal birthweight individuals
born in Edinburgh.
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If a system has been programmed by events in intrauterine life then abnormalities of
that system should be detectable early in the development of abnormal functioning of
that system. Evidence for programming of vascular structure is considered in the
premature delivery cohort, and described in chapter 3, and in a separate cohort of
schoolboys in chapter 4. Chapter 4 also examines parental influences on the
relationship between blood pressure and birthweight, and considers the role of socio¬
economic factors in more detail.
Interrelationships between blood pressure, insulin resistance and vascular structure
have been described in the final section of the introduction. Chapter 5 reports an
analysis of assessments of microvascular structure and function in healthy young
men drawn from a cohort of differing familial predisposition to hypertension. This
work explores functional implications of alterations in microvessel physiology which
are relevant to the hypothesis that vascular structure may be programmed by events
that influence birthweight.
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Chapter 2: The influence of premature delivery on adult
cardiovascular risk factors.
Premature delivery exposes an infant to greatly increased perinatal morbidity and
mortality. It also accounts for an important proportion of population birthweight, as
5-10% of individuals are born prematurely, and a large part of attained birthweight
occurs during third trimester growth. It is perhaps curious that this profound event
did not seem to influence relationships between birthweight and subsequent blood
pressure in the early studies. Closer examination of the literature shows that an
influence of birthweight can be demonstrated, and that it has been a minority of
studies that have had information on gestation. This study examines the hypothesis
that premature delivery programmes subsequent cardiovascular risk.
In the Simpson Memorial Maternity Pavilion in Edinburgh between November,
1973, and February, 1975, mothers of 72 low-birthweight (<2000 g) babies agreed to
participate in the study. As controls, mothers of 54 normal birthweight (>2000 g)
babies born on the same day and matched for sex, birth order, and father's social
status, were also recruited. This was conceived as a study of outcome of low
birthweight, with particular reference to nutritional factors. Gestational age was
estimated from the mother's last menstrual period and by developmental assessment
by a paediatrician. Low-birthweight babies were classified as either appropriate
weight for gestational age (n=30) or having IUGR (n=42) by means of a cut-off of
the 10th centile on Gairdner-Pearson growth charts (GAIRDNER 1971). Detailed
records were compiled for parents and offspring. Parental data included adult height
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and weight and birthweight. Categorised details were recorded of the neonatal
period, unfortunately not including maternal BP. The infants were closely followed
up with detailed anthropometric measurements recorded at least every 4 weeks until
1 year of age, and less frequently until 7 years of age. The infants diet was based on
powdered milk which allowed for remarkably detailed calculations of dietary
components. Mothers weighed every item of food 3 days per week for one year.
Their childhood growth, nutrition and development has been reported previously
(BELTON 1986).
In 1998-99 we contacted 81 of the original 126 babies. Of these, 61 consented to a
further study approved by the local ethics committee. Parental and offspring






Mothers age (years) 26.0 24.6 0.10
Social class 3.2 2.9 0.12
Placental Weight (g) 587.0 559.1 0.50
Apgar 1 minute 6.6 6.8 0.63
Apgar 5 minutes 8.9 9.0 0.49
Maternal Height (cm) 158.5 158.9 0.73
Maternal weight (kg) 55.4 55.3 0.97
Paternal Height (cm) 173.6 174.6 0.49
Paternal weight (kg) 73.4 71.0 0.12
Days of prematurity 22.9 25.4 0.59
Birthweight (g) 2358 2321 0.80
Participants attended the hospital at 0900 h having fasted from midnight. Females
attended during the follicular phase of their menstrual cycles. Height, weight, and
abdominal and hip circumferences were recorded before participants sat and
acclimatised to a temperature-controlled environment (23-25°C) for 10 min. Blood
pressure was recorded in the right arm by means of an automated
sphygmomanometer (Omron HEM 705CP Hutchings Healthcare, Henfield, UK).
The mean of two recordings was used for analysis, unless they differed by >5 mm
Hg in which case a third recording was made and the mean of two closest matches
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was used. Venous blood was obtained to measure glucose by an enzymatic technique
(Capas Mira Plus, Roche Diagnostics, Lewes, UK), insulin by enzyme immunoassay
(Eurogenetics Tasah, Hampton, UK), and lipids by dry slide principle (Vitras 950,
Ortho Clinical Diagnostics Amersham, UK). The clinical investigator (myself) was
masked to the birthweight of participants until data collecting was complete.
Statisitics
Data are presented for the three groups, low birthweight babies who were appropriate
for gestational age (AGA), low birthweight babies that had intra-uterine growth
retardation, (IUGR) and controls. Group comparisons were tested by unpaired
student t test. Regression analyses were made using the combined groups.
Results
Low-birthweight premature babies had higher adult blood pressure and fasting
plasma glucose than normal birthweight controls born at term (table 2.2). Among
low-birthweight babies there was no difference in blood pressure or plasma glucose
between those whose low birthweight was appropriate for gestational age and those
who had IUGR. Other cardiovascular risk factors were not significantly different
between groups, but there were trends for an adverse metabolic profile (higher
plasma insulin, triglyceride, and total cholesterol, and lower high-density lipoprotein
cholesterol) in the group with appropriate weight for gestational age rather than the
IUGR group.
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Table 2.2 Data are mean ± SD. Comparisons were made between controls and all low














11 / 16/4 13/21/4 9/10/2 4/11/2
Birthweight (kg) 3.13 ±0.45 1.68 ± 0.22 ** 1.66 ±0.22 1.70 ±0.22
Gestational age at birth (wk) 39.3 ± 1.9 33.4 ± 2.3 ** 31.9 ± 1.5 35.2 ±1.7 **
Weight at term (kg) 3.08 + 0.41 2.82 ± 0.33 3.05 ± 0.24 2.60 ± 0.24 **
Age when studied (y) 24.0 ± 0.7 24.3 ± 0.5 24.4 ± 0.4 24.3 ± 0.6
Adult height (m) 1.68 ±0.10 1.67 ± 0.09 1.70 ±0.08 1.63 ±0.09*
Adult weight (kg) 64.9 ± 11.1 66.9 ± 12.7 71.7 ± 13.4 60.8 ±8.7**
Adult systolic blood pressure
(mmHg)
115 ± 9 122 ± 12 * 123 ±9 120 ± 14
Adult diastolic blood
pressure (mmFIg)
73 ±7 78 ± 7 * 80 ±7 77 ±6
Fasting plasma glucose
(mmol/1)
4.2 ±0.4 4.5 ± 0.4 * 4.4 ± 0.4 4.6 ±0.3
Fasting plasma insulin
(mU/1)
4.9 ±2.8 5.1 ±2.0 5.6 ±2.1 4.3 ±1.6
Fasting plasma triglyceride
(mmol/1)
0.8 ±0.3 0.9 ±0.3 0.9 ±0.4 0.8 ±0.3
Total plasma cholesterol
(mmol/1)
4.0 ±0.9 4.3 ±0.9 4.5 ± 1.0 4.0 ±0.6
plasma HDL cholesterol
(mmol/1)
1.4 ±0.3 1.4 ±0.3 1.3 ±0.3 1.5 ±0.3
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Eight twin pairs participated in the study; after exclusion of twins from the analysis, the
differences between groups described in table 2 remained significant except for fasting
plasma glucose (4-2 [0-3] mmol/L in controls; 4-4 [0-3] in low-birthweight babies,
p=0-06).
Confounding by parentalfactors?
These observations were confirmed in linear regression analyses; both lower birthweight
and shorter gestation were associated with higher blood pressure (systolic r=-0-26;
p<0-05 for birthweight and r=-0-32; p<0-02 for gestation), fasting plasma glucose (r=-
0-32, p<0-02 and r=-0-27, p<0-05, respectively), and total plasma cholesterol (r=-0-31,
p<0-03 and r=-0-32, p<0-02, respectively). However, the effects of birthweight were not
independent of the effects of gestation (for birthweight adjusted for gestation r=0T0,
p=0-70 for systolic blood pressure; r=-0-34, p=0-20 for plasma glucose; and r=-0T5,
p=0-85 for cholesterol). That is to say that growth retardation is not sine qua non for the
association with adult phenotype. These associations with birthweight were independent
of other potential confounders, including sex, placental weight, indices of adult obesity,
smoking, current medication, and social class in fathers of offspring. Very few mothers
had high blood pressure during pregnancy, unfortunately actual blood pressure values
were not recorded, but only 5 had high blood pressure. There was no detectable
influence from maternal blood pressure on birthweight or adult blood pressure.
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Table 2.3
St. Err. St. Err.
Beta of Beta B ofB p-level
Birthweight -0.28 0.12 -3.81 1.70 0.03
Male sex 0.38 0.12 8.52 2.74 <0.01
BMI (kg/m2) 0.05 0.13 0.17 0.45 0.70
Current smoker 0.03 0.12 0.07 0.30 0.82
Current medication -0.11 0.13 -2.11 2.37 0.38
Maternal smoking -0.02 0.13 -0.24 1.29 0.86
Social class -0.01 0.12 -0.09 1.21 0.94
Placental weight -0.07 0.12 0.00 0.01 0.54
Table 2.3
Multiple regression model predicting systolic blood pressure.(R= 0.51, R2^ 0.26). Sex,
smoking and regular prescription medication were scored as dummy variables, Social
class was scored from 1 to 5 according to paternal occupation. In simultaneous multiple
regression, male sex and lower birthweight remain significant predictors of higher blood




By the time all babies had reached term, the appropriate for gestational age-group were
similar in weight to controls, while IUGR babies remained smaller. Even by this early
stage of infancy, the inverse links between bodyweight and adult blood pressure
(r=0-21), plasma glucose (r=-0-05), and total cholesterol (r=-0-02) were no longer
apparent; nor did weights measured in any later 4-week period up to the age of 1 year
predict adult blood pressure or biochemistry (data not shown).
We calculated growth rates in absolute terms, and in growth per kg weight, from birth to
term and from term to 44 weeks after last maternal menstrual period, but no measure of
growth rate predicted adult blood pressure, (data not shown). In a multiple regression
model using sex, birthweight and current weight as predictors, birthweight was a strong
independent predictor of blood pressure but current weight was not a significant
predictor. The same result was obtained for each of glucose, cholesterol and LDL
cholesterol.
Potential programming influences ofearly neonatal life
Premature delivery exposes the neonate to a very different environment to the baby
growing safely attached to a placenta. Information was collected on numerous obstetric
and neonatal factors, but they did not predict adult factors independently of gestational
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age. This study is too small to answer questions as to which aspect of premature delivery










6 7 8 9 10
5 minute APGAR score
This graph shows adult blood pressure according to 5 minute Apgar score. This is a
clinical score on 5 criteria scored from 0 to 2 on criteria of heart rate, respiration, muscle
tone, response to pharyngeal catheter and colour of trunk. A low score indicates that
parturition has exposed the infant to hypoxia. In addition a low score predicted higher
blood pressure as an adult (r=-0.27, p=0.03). A similar association was seen with Apgar
score at 1 minute (r=-0.25, p=0.05). However, these associations were confounded by
premature delivery in multiple regression analysis, (not shown).
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Table 2.4 Infant characteristics of participants
Males Females p-value for sex
differences
n 24 37
Birthweight (kg) 2.37 ± 0.92 2.29 ± 0.73 0.68
Gestational age at birth (weeks) 35.8 ± 0.74 36.7 ± 0.66 0.89
Body weight at term (kg) 3.06 ± 0.33 2.86 ± 0.40 <0.05
Body weight at 1 year after estimated
term date (kg)
9.05 ± 1.1 8.39 ± 0.9 0.01
Average nutrition from term to 8 weeks
of age
Fat (g/day) 21.65 ±4.2 19.06 ± 3.4 0.02
Carbohydrate (g/day) 54.33 ± 11.5 53.93 ± 12.1 0.91
Protein (g/day) 19.83 ±4.4 18.52 ± 3.4 0.24
Energy (kcal/day) 482.1 ± 82 451.6 ± 74 0.18
Sodium (mg/day) 364.0 ± 97 345.4 ± 70 0.40
Data are mean ± SD.
Infant nutrition was measured for major dietary components (see table 2.4). Daily intake
was averaged for time period until 1 year of age (measured from term). There were no
associations between intake of macro-nutrients or minerals during infancy and adult
characteristics for any time period (e.g. average daily sodium intake during the first
eight weeks after birth versus adult systolic blood pressure r=-0.18, p=0.17).
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Discussion
By contrast to the hypothesis that growth retardation in utero mediates programming of
adverse cardiovascular risk in babies bom at term, we found that among premature
babies, those with IUGR were not measurably more disadvantaged than those with
birthweights appropriate for gestational age. This is a novel finding that challenges the
hypothesis that adult outcomes are the result of decreased intrauterine growth. Careful
attention to measurement of, and adjustment for, gestational age should be part of every
study of the influence of birthweight. This study, and the other studies showing a
relationship between prematurity and higher blood pressure, suggest that there may not
be a single mechanistic explanation for the associations between adult cardiovascular
risk factors and low birthweight due to premature delivery, and low birthweight due to
IUGR, as prematurity and IUGR result from many and disparate influences (described in
detail in the introduction).
This is a small study with limited power to determine the relative effects on adult
outcomes from IUGR with or without premature delivery. Much larger follow up studies
have been performed and demonstrated independent influence of premature delivery,
and of birthweight (LEON 2000) on blood pressure in adolescence, although babies born
more than 35 weeks gestation were excluded. Similarly, although we had detailed,
prospectively collected data on obstetric and neonatal problems, we have insufficient
power to determine what specific features of the experience of the premature infant
predict higher blood pressure, glucose and lipid concentrations in adulthood. Larger
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cohorts of survivors of extremely premature deliveries have been studied in regard to
their educational attainment. It would be interesting to measure cardiovascular risk
factors in further studies of these cohorts (HALL 1995, LEFEBVRE 1988, WARIYAR
1989).
In this study adult size had little predictive effect on adult risk factors, and growth rates
in childhood did not predict adult outcomes. Indeed, repeated measurements of weight
during infancy confirmed that participants in the in all groups grew at similar rates.
Individuals who had IUGR did not catch up with the AGA group, who had caught up
with the controls at 40 weeks gestation. According to Lucas' analysis (LUCAS 1999)
this implies that pre-natal factors are more important than post-natal growth. In this
study, the dominant pre-natal influence on birthweight is premature delivery, but this is
not a single parameter, resulting as it does from many influences. The dominant
statistical influence of prematurity may still be a surrogate for the extra-uterine
environment during what otherwise would have been the third trimester.
Lower Apgar score was associated with higher blood pressure but no control individuals
had very low Apgar scores, so we have no power to test whether hypoxia at birth
predicts higher pressure independently of prematurity. This could be tested in analyses
of other cohorts described above.
We examined early nutrition using nutritional values obtained by weighing the formula
intake of the infants, but did not demonstrate an influence on adult factors. This is
compatible with the results reported by Lucas et al. demonstrated that blood pressure
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was lower in grown-up premature babies who were randomised to pooled breast milk,
and not measurably different between groups randomised to different formula
preparations (SINGHAL 2001).
Prematurity is frequently associated with pre-eclampsia, and though we could not
demonstrate an association with maternal hypertension in our data, this reflects lack of
power. Maternal pre-eclampsia could influence blood pressure through shared genetic
influences on blood pressure in addition to mechanisms that relate to premature
delivery.
In conclusion, this study, though small, raises interesting questions about many aspects
of nenonatal life that might act as programming influences on later cardiovascular risk.
Larger studies of survivors of extreme prematurity, matched to appropriate controls,
may provide more definitive answers to these questions.
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Chapter 3: Higher adult blood pressure in premature low birthweight
babies, evidence for programming of vascular structure.
The introduction to this thesis described vascular structural abnormalities that are
present in high blood pressure, and an outline of how the developmental principles that
govern these changes could lead to programming of high blood pressure by early events.
This possibility has been investigated in other studies.
Intrauterine manipulations which retard fetal growth in animals can permanently alter
fetal cardiac and peripheral vascular structure (MUROTSUKI 1997). There is evidence
that adult men born at term with low body weight have altered structure of conduit
vessels, indicated by decreased compliance assessed by ultrasound (MARTYN 1995),
and altered structure of smaller vessels in the retina, indicated by altered arteriolar
branching that suggests a rarefied microvasculature (CHAPMAN 1997). In studies of
young adults, changes in microvascular structure have been associated with
predisposition to hypertension (NOON 1997) and diabetes mellitus (JAAP 1997), so
these may be an important link between events in early life and subsequent
cardiovascular risk factors.
It has proved more difficult to relate cardiac structure, measured by transthoracic
echocardiography, with parameters at birth, although two studies suggested a link
between body weight between 9 months and 2 years of age with left ventricular mass in
adulthood (VIJAYAKUMAR 1995, ZUREIK 1996). There is a large body of evidence
suggesting that ventricular hypertrophy occurs early in the development of hypertension
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(DEVEREUX 1991). Moreover, left ventricular hypertrophy is an important
cardiovascular risk factor, independently of its association with hypertension (LEVY
1990), so programming of cardiac development could contribute to the high prevalence
of adult cardiovascular disease in low birthweight babies.
Many epidemiological studies in this area have examined babies born at term, but in the
modern era of neonatal care, most surviving low birthweight babies are born
prematurely. The second chapter described cardiovascular risk factors in a cohort of
individuals including premature, low birthweight babies. In this chapter we explore the
possibility that vascular structure has been programmed in these individuals.
Methods
The characteristics of participants have been described in chapter 2.
Protocol
In addition to the measurements described in chapter 2, further detailed assessments of
vascular structure were made. Subjects completed a nutritional and exercise
questionnaire (exercise scored as 0 or 1, according to whether subjects took aerobic
exercise at least three times each week). The following measurements were made in
sequence by a single observer (myself) who was blind to the birthweight group of the
participants. Further details of several of these measurements and their validation have
been published previously (NOON 1997).
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2. Pulse wave analysis was performed in the right radial artery (Sphygmocor, PWV
Medical, Australia). Augmentation index (that is the ratio between calculated central
pressure, and measured peripheral pressure) was derived using the validated
transformation factor. This measure has been validated in our laboratory
(WILKINSON 1998).
3. Maximum vasodilatation of skin microvessels was measured by laser Doppler
fluximetry in response to local heating to 42°C. A 1cm brass heating element (Moor
instruments Ltd. Devon) was applied to the volar aspect of the left forearm. The skin
temperature was monitored with a thermocouple which passed though a hole in the
heating element. After 30 minutes the thermocouple was removed and a laser
Doppler probe was placed through the hole. The heater was rotated through 8
positions and the signal recorded in each area for 30 seconds. To record biological
zero flux, a sphygmomanometer cuff was applied to the upper arm and inflated to
supra systolic pressure for one minute. Minimum dermal vascular resistance was
calculated as (mean arterial pressure)/[(mean of 8 maximum flux recordings) -
(biological zero)] (NOON 1997).
4. Dermal capillary density was recorded on the dorsum of the middle phalanx of the
right index finger by intravital videomicroscopy. The skin was prepared with a
coating of clear nail varnish. Dermal capillaries were visualised using a microscope
(Leitz; Leica UK, Milton Keynes, UK) under illumination with a mercury filament
lamp (Leitz). Six adjacent fields of 0.25 mm2 were recorded via a television camera
(Phillips LDH0703; KRP Power Source, Newbury, UK) onto videotape for one
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minute at baseline and again after 10 minutes of venous occlusion, achieved by
inflating a cuff (Peni-cuff; Hokanson, Belleview, WA) to 40mmHg around the base
of the finger. Calibration was checked periodically with a graticule (Graticules Ltd.,
Tonbridge, UK). Counting of capillaries was performed at a later date. Thus the
investigator was not aware of the blood pressure of participants during analysis.
5. Ultrasound images of the heart were recorded using an Accuson xl750 (Mountain
View, CA). Using 2D echo in the parasternal long axis view, the M mode cursor was
positioned through the tips of the mitral valve leaflets. M-mode images of sufficient
clarity to analyse were obtained in 59 individuals, but in 12 the orientation of the
probe was oblique and these images were not included in the final analysis.
Characteristics of subjects in whom echocardiography was technically unsuccessful
were not different from other participants (data not shown). Analysis was performed
at a later date. Left ventricle (LV) dimensions were calculated according to the ASE
convention. The mean dimensions from 3 cardiac cycles were used to calculate LV
mass according to the formula: LV mass (g)=0.832[(IVS+LVEDD+PWT)3-
(LVEDD)3]+0.6, where IVS is intra-ventricular septum width, LVEDD is left
ventricular end diastolic diameter, and PWT is posterior wall thickness. LV mass
index (LVMI) was calculated by dividing LV mass by body surface area, calculated
as 0.20247 x height(m)0 725 x weight(kg)0425, as previously validated (DEVEREUX
1986). Aortic root area was also quantified using 2D echo via the parasternal long
axis. From the apical view, continuous wave Doppler flows through the mitral and
aortic valve were recorded during 6 cardiac cycles and the mean calculated to
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overcome effects of respiration. Cardiac output was calculated as (aortic velocity
time integral) x (aortic root area) x (heart rate). Cardiac index was calculated as
cardiac output/body surface area. Diastolic function was assessed using E/A ratio
(SCHIRMER 2000).
6. Common carotid artery intima-media thickness was measured using an Accuson
7mHz linear phase array probe. The posterior wall of the artery was imaged 1 cm
proximal to the carotid bifurcation. Measurements were averaged from left and right.
(HOWARD 1993)
7. Forearm blood flow was measured by venous occlusion plethysmography, at baseline
and after ischaemia in the left arm. The arm was supported above the level of the
heart. Cuffs were applied to the upper arm and wrist and a mercury-in-silastic strain
gauge applied to the forearm, with internal calibration (Hokansen, Belleview WA).
During measurements, the wrist cuff was inflated to 220 mmHg to exclude the hand
circulation and the upper arm cuff was inflated to 40 mmHg for 10 sec in every 15
sec to occlude venous return and measure forearm blood flow. Baseline flows were
recorded for three minutes and calculated from the average of the last five flows.
Then, an upper arm cuff was inflated to supra-systolic pressure for 12 minutes. Flows
were recorded immediately after release of the cuff and the average of the first five
flows used for analysis of maximum forearm blood flow. Forearm vascular resistance
was calculated as (mean arterial pressure)/(forearm blood flow) (NOON 1997).
90
Statistics
Data were tested for normal distribution using a Shapiro Wilks W test. Birthweight was
not normally distributed and relationships with adult parameters were tested using
Spearman rank correlation. All indices of vascular structure were normally distributed
except maximum forearm blood flow, which was normalised by logarithmic
transformation, and LVMI, which was normalised using a negative inverse root
transformation (ie LVML05). No simpler transformation (natural or base ten logarithms)
conferred normality. Multiple linear regression analyses were used to examine the
influence of birthweight after adjustment for potential confounders in early and adult
life. Data are presented in the text as mean ± SD.
Results
Characteristics and confounders
Characteristics of participants, and differences between adult measurements in male and
female participants are shown in Table 2.4. No differences between these variables were
observed in participants who were twins or triplets (n=17) compared with singletons, or
in those taking regular medication (n=18: including 6 taking oral contraceptives).
Current smokers (n=ll) differed from non-smokers only in having a higher E/A ratio
(2.1± 0.37 vs 1.8 ± 0.36, p=0.03). Subjects taking exercise at least 3 times per week
(n=15 males, n=10 females) tended to have higher LVMI (LVMI amongst men 107.8
g/m2 ± 25.5 with exercise vs 91.8 ± 18.4 without, p=0.06; amongst women 82.2 ± 21.4
with exercise vs 69.8 ± 10.1 without, p=0.12), than subjects not taking exercise.
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Relatively few haemodynamic variables correlated with each other. Higher blood
pressure was associated with higher LVMI (for mean arterial pressure r=0.47, p<0.001).
Lower heart rate was associated with higher LVMI (r=-0.52, p<0.001) and higher E/A
ratio (r=-0.36, p<0.01).
Relationships between measurements in early and adult life
Relationships between measurements in infancy and adult haemodynamic variables are
shown in Table 3.2 after adjustment for potential confounders identified above. Low
birthweight or premature delivery were associated with higher adult blood pressure and
LVMI, independently of measured confounders including gender, blood pressure (for
LVMI only), and exercise. (See table 3.1) The effects of gestational age at delivery and
birthweight were not independent of each other. Measurements in infancy did not
predict any other measured haemodynamic variables.
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Table 3.1
Multiple regression model predicting (transformed) LVMI
St. Err. St. Err.
BETA ofBETA B ofB p-level
Exercise -0.300 0.105 -0.008 0.003 0.007
Male sex -0.231 0.124 -0.006 0.003 0.071
Systolic BP -0.321 0.117 0.000 0.000 0.009
Heart rate 0.221 0.116 0.000 0.000 0.063
Birthweight 0.213 0.103 0.004 0.002 0.046
R=0.79, R2= 0.63 Adjusted R2= 0.58, F(5,41)=13.671 p<0.001
This multiple regression model describes independent predictors of adult (transformed)
LVMI. The transformation reverses the polarity of the association. Thus greater
birthweight is associated with greater (transformed) LVMI. Reversal of the
transformation following multiple regression analysis is not mathematically possible.
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Figure 3.1 Relationship between low birthweight and higher adult left ventricular
mass index
This graph shows the effect of birthweight on (unadjusted) left ventricular mass index
(LVMI). Spearman rank correlation coefficient R=-0.29, p<0.05. This relationship
persisted in multiple regression analysis (following normalisation) adjusting for
potential confounding effects of sex, exercise, heart rate, and systolic blood pressure
(adjusted r = -0.20, p<0.05).
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By contrast with the inverse relationship between birthweight and adult LVMI and
blood pressure, body weight measured at term (ie 40 weeks after the mother's last
menstrual period) and at intervals up to 1 year of age did not predict adult
haemodynamic variables (Table 1). This suggests that premature babies destined to
higher adult LVMI had completed their 'catch up' growth by their term date. However,
calculated growth rates between birth and term did not predict adult variables (eg
growth rate between birth and term versus adult systolic blood pressure r=-0.04, p=0.79;
and LVMI r=0.04, p=0.81).
Remarkably detailed records were kept of infant nutrition during this period of'catch-up'
growth. An apparent correlation between increased intake of fat and higher LVMI, (eg
daily fat intake weeks 1 to 8 vs LVMI, (r=0.47, p=0.004) was confounded by sex in
multiple regression.
Discussion
These data show that adults in whom low birthweight was associated with premature
delivery, have increased left ventricular mass over and above that which is predicted
from their elevated blood pressure. Moreover, the increased adult left ventricular mass
occurs in small babies who had normal body weight by one month after their estimated
term date (IRVING 2000). Since premature babies who have 'caught up' to normal size
by term are unlikely to have suffered intra-uterine growth retardation this suggests that
increased LVMI may be the consequence of premature delivery rather than impaired
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intrauterine growth. Alternatively, catch up growth in premature babies may predict LV
Mass, but we did not confirm this.
This interpretation is consistent in part with larger studies of babies born at term (ie
excluding those delivered prematurely) which showed no relationship between
birthweight and adult LVMI, albeit that in these studies there were inverse relationships
between adult LVMI and body weight between the ages of 9 months and 2 years
(VIJAYAKUMAR 1995, ZUREIK 1996). Offspring of mothers who had hypertension
(>140/90 mmHg) during pregnancy have higher blood pressure than controls bom to
normotensive mothers, but LVMI was not different between the groups
(HIMMELMANN 1993). In 435 Indian men and women, there was no relationship
between birthweight and LVMI (KUMARAN 2000). Length of gestation is not recorded
in these papers.
The "Barker Hypothesis" infers from detailed anthropometric measurements at birth,
that there are specific temporal 'windows' during development when retarded growth can
programme subsequent disease (BARKER 1993) Specifically, late intrauterine growth
retardation, indicated by disproportionate linear growth and weight (low ponderal
index), is thought to predict insulin resistance while early intrauterine growth
retardation, indicated by proportionate growth retardation, predicts hypertension
(BARKER 1993). Extending this model, the current data suggest that altered early post¬
natal growth and development may predict left ventricular hypertrophy. In animals, a
temporal window of cardiac myocyte development is recognised, since there is a switch
from a hyperplastic to a hypertrophic response to stimulation near term eg in rats
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(RAKUSAN 1985, RAKUSAN 1998). In humans, left ventricular mass index increases
by around 20% in the first month of life to accommodate the demands of sustaining the
systemic circulation without the assistance of the right ventricle provided in utero
(ICHIHASHI 1999). In premature babies, the increasing mechanical demands on the left
ventricle are imposed earlier, perhaps at a time when there is still the capacity for
myocyte hyperplasia rather than hypertrophy.
We did not find any evidence to support the hypothesis that peripheral vascular structure
is 'programmed' by early life events. However, these results must be interpreted with
caution. The number of participants in this study was relatively small. Moreover, the
low birthweight babies in this study were all delivered prematurely, and the study had
insufficient power to address factors associated with variation in birthweight amongst
babies born at term. Previous studies have demonstrated altered vascular structure in
adults with low birthweight. Martyn et al found decreased iliac artery compliance in
middle aged men who had been low birthweight babies (MARTYN 1995). It is possible
that this finding represents a consequence of their increased blood pressure as
birthweight was not shown to have an influence on arterial compliance in 951 men and
women aged 25 years (MONTGOMERY 2000). Chapman et al showed decreased
retinal vascular density in low birthweight members of a study of 100 middle aged men
(CHAPMAN 1997). Gestational age was not recorded in this cohort.
Animal studies have suggested that early nutrition may have a long term influence on
adult outcomes (GOULDSBOROUGH 1998, LANGLEY-EVANS 1996), but a previous
study of human neonates who were randomised to different diets showed no effect on
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blood pressure at the age of 8 years (LUCAS 1994). Our study had detailed,
prospectively collected nutritional data for the first year of life and cardiovascular data
in adulthood but we did not find associations between different compositions of early
nutrition and adult cardiovascular risk factors.
In summary, in addition to higher blood pressure and other biochemical risk factors for
cardiovascular disease, premature babies have greater left ventricular mass in early
adulthood. This may represent both a marker for greater subsequent rises in blood
pressure in these individuals, and a marker for their early vascular death.
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Chapter 4
Higher childhood blood pressure in boys attending a fee paying school,
evidence for programming of vascular structure
The study described in the previous chapters has described cardiovascular risk factors in
a group of adults in whom low birthweight was the result of premature delivery. This
chapter discusses the results of a different study that examines further questions that
arise from the descriptions of associations between early growth and adult blood
pressure.
It has been a persistent criticism of the programming hypothesis that potential
confounding has not been eliminated (PANETH 1995, JOSEPH 1996, KRAMER 2000).
Social deprivation is associated with both low birth weight and higher blood pressure in
later life (COLHOUN 1998), and assessments of social class in cross-sectional studies
may be insufficiently subtle to eliminate confounding (JOSEPH 1996). Deprivation may
vary to a greater extent within social class than between classes, or may change between
birth and measurement of the risk factor in question.
A further uncertainty is whether, if programming of high blood pressure occurs, it
results from events occurring before or after birth. Several studies have examined
relationships between birthweight and measurements in childhood. (FORRESTER 1996,
HASHIMOTO 1996, TAYLOR 1997, WHINCUP 1995, WHINCUP 1996, WHINCUP
1996, WOELK 1998) As in some studies of adults, lower birthweight predicts higher
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blood pressure only when adjusted for indices of current size. One interpretation of these
associations is that faster childhood growth determines a more rapid rise of blood
pressure, and there is no programming effect from foetal growth. (LUCAS 1999)
Against this background, this study examined the hypothesis that low birthweight is
associated with higher blood pressure and diminished capillary density in childhood. By
studying boys attending a fee paying school we aimed to minimise confounding from
socio-economic deprivation.
Subjects and methods
We studied boys attending George Watson's College, a private, fee paying school in the
south of Edinburgh. Participants were chosen at random from each year group from the
ages of 6 to 16 years. Parents of 110 boys were sent a questionnaire requesting details of
parental size, offspring birthweight, and their informed consent. Only 3 declined to
allow their sons to participate. Maternal recall of birthweight has been previously shown
to be accurate in adults (WALKER 1998, TROY 1996, LUMEY 1994). Ethical approval
was obtained from the local research ethics committee.
The study protocol lasted for half an hour. The studies were performed during the school
day in a quiet room. Height, weight and waist hip ratio was recorded before the subject
reclined on a couch. After one minute blood pressure was recorded once in the left arm
using an automated sphygmomanometer (Omron HEM 705CP).
102
A similar technique for assessment of capillary density was used in both studies in this
thesis. To maximise the number of perfused capillaries, venous occlusion was achieved
by inflating a cuff (Peni-cuff; Hokanson, Belleview, WA) to 40mmHg around the base
of the finger. Capillary density following venous occlusion represents the maximum
capillary number (ANTONIOS 1999 B). After 10 minutes six adjacent fields of 0.25
mm2 were recorded via a television camera (Phillips LDH0703; KRP Power Source,
Newbury, UK) onto videotape for 30 seconds. Calibration was checked periodically
with a graticule (Graticules Ltd., Tonbridge, UK).
Capillary counting was performed between 6 and 12 months after the study. Although I
had collected the data on birthweight and blood pressure, the passage of time ensured I
was effectively blinded to these data. Statistical tests were performed using Statistica
software (Statsoft Inc.). Regression slopes (B coefficients) were calculated and are
expressed with 95% confidence intervals.
Results
Characteristics of participants are recorded in Table 4.1. Blood pressure increased with
greater age (slope=2.02 mmHg per year, r=0.50 , p<0.0001), height (slope=0.32 mmHg
per cm, r= 0.53, p<0.0001) and weight (slope=0.47 mmHg per kg, r=0.66 , p<0.0001).
Birthweights were normally distributed in the population (Mean 3.41 kg, range 1.35 -
5.06 kg, Shapiro wilks w test not significant).
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Predictions from Birthweight:
Lower birthweight predicted lower childhood height, after adjustment for age (2.90cm
per kg birthweight (95% confidence intervals 0.59 - 5.21, p=0.01)), but did not predict
age adjusted weight (1.37kg per kg birthweight (-1.62 - 4.35, p=0.36)), or BMI(-
0.10kg/m2 per kg birthweight (-1.03 - 0.82, p—0.82)). In simple regression, birthweight
did not predict systolic BP (r=-0.14, p=0.15), or diastolic BP (r=0.05, p=0.61). In
multiple regression, after adjusting for the effects of age, height and weight on blood
pressure, lower birthweight was shown to predict higher systolic blood pressure (Table
2). Diastolic BP was not significantly predicted by birthweight in similar analyses (data
not shown).
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Parental size predicted birthweight and size of the offspring in childhood. The
associations were stronger for mothers than fathers, and for parental height rather than
weight or obesity. Thus, lower birthweight was associated with shorter mothers (37g per
cm maternal height (19-56, p<0.0005)), and shorter fathers (17g per cm paternal height
(-10 - 360, p=0.06)). Taller children were born to taller parents (0.47cm per cm
maternal height (0.24 - 0.70,p=0.0001) and 0.34 cm per cm paternal height (0.11 - 0.56,
p=0.003)). However, parental size did not predict offspring blood pressure. There were
no significant correlations between systolic blood pressure and maternal height (r=-0.05,
p=0.62), maternal weight (r=-0.07, p=0.48), paternal height (r=-0.03, p=0.75) or paternal
weight (r=-0.001, p=0.99).
Capillary Density:
Capillary density was not measurable in 9 subjects. Data were rejected from a further 4
subjects in whom fewer than 5 fields were countable. Technical failures occurred
because of poor skin preparation or excessive movement. Younger age correlated with
fewer countable fields (r=0.30, p=0.002).
In simple regression, capillary density was not significantly associated with birthweight
(r=-0.01, p=0.91, graph 4.1), systolic (r=-0.03, p=0.77) or diastolic blood pressure
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(r=0.01, p=0.96) In multiple regression, capillary density did not confound associations
between birthweight, current height or weight and systolic blood pressure (Table 4.2).
Capillary density
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birthweight -3.57 -6.75 -0.38 0.03
age -0.40 -2.23 1.42 0.66
height 0.39 0.11 0.67 0.01
Model 2:
birthweight -3.22 -5.95 -0.50 0.02
age -0.74 -1.76 0.28 0.15
weight 0.58 0.40 0.76 <0.01
Model 3:
birthweight -3.36 -6.27 -0.46 0.02
age -0.67 -1.76 0.43 0.23
weight 0.58 0.39 0.77 0.00
capillary density 0.23 -0.29 0.76 0.38
Table 4.2
Multiple regression models showing predictors of systolic blood pressure. Omitting age
from the analyses did not alter the association between birthweight and blood pressure.
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Discussion
This study examined relationships between birthweight and blood pressure, dermal
capillary density, height, and weight during childhood. In 107 private school pupils low
birthweight was associated with higher systolic blood pressure, after adjustment for
current size. As in the other study cohort described in chapter 3, we did not find
evidence of changes in capillary density that might mediate the association between
birthweight and blood pressure.
Low socioeconomic status predicts low birthweight through several mechanisms.
Features of low socio-economic status during pregnancy such as lower maternal age,
exposure to illicit drugs, low maternal weight gain and shorter inter-pregnancy interval
are independent predictors of premature delivery. (ABRAMS 1989) An association
between low socio-economic status and intrauterine growth retardation is explained by
maternal smoking. (BROOKE 1989) Participants in our study were drawn from a
narrow and privileged social spectrum, and though we cannot exclude the possibility of
some confounding as we collected limited information on parental factors and did not
request information on maternal smoking, it is unlikely that the subjects in our study had
been exposed to the pervasive influences of poverty. This supports the conclusion of
previous cross-sectional studies that the observed association between low birthweight
and higher blood pressure is mediated by influences other than socioeconomic
deprivation.
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As previously reported (FORRESTER 1996, HASHIMOTO 1996, TAYLOR 1997,
WHINCUP 1995, WHINCUP 1996, WHINCUP 1996, WOELK 1998) the association
between birthweight and blood pressure was only seen after adjustment for the effect of
current size. Current size is the product of both genetic and environmental influences,
and potentially subject to the influence of deprivation. In this population parental height
was a strong predictor of birthweight and also a predictor of current size. However,
parental size did not predict blood pressure, suggesting that the factors that mediate the
inheritance of birthweight and of current size are not those that mediate the associations
between low birthweight and higher blood pressure in an advantaged population.
We did not find a role for programming of dermal capillary density in boys aged 6-16
years, in keeping with similar observations in infants. (GOH 2001) Neither of these
studies exclude the possibility that capillary density in other vascular beds may be
influenced by birthweight. An association between birthweight and post ischaemic
capillary recruitment in nail fold capillaries has been reported by Serne et al. (SERNE
1999) in a small study (n=30) which did not report any association with absolute
capillary number. A detailed discussion of the differences between the methods used by
Serne and our lab appears in the next chapter. The current study had similar power to
detect capillary rarefaction as a previous study of young adults with contrasting
inherited predisposition to high blood pressure. (NOON 1997) It seems that capillary
rarefaction may occur later in the pathogenesis of hypertension than childhood. This is
consistent with Lever's hypothesis (LEVER 1992) that childhood growth is associated
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with rising blood pressure, but subsequent vascular structural change is responsible for
maintenance of increased pressure. Indeed, a previous study of middle-aged men did
show a relationship between low birthweight and altered microvascular structure, albeit
in the retinal circulation. (CHAPMAN 1997)
In conclusion, we have demonstrated that the effects of low birthweight can be seen in
the blood pressures of relatively privileged schoolchildren. This study also adds to the
evidence from the previous chapter that dermal capillary density is not programmed by
early life events. In the next chapter, we shall review evidence for a link between insulin
resistance and hypertension that is mediated by capillary density.
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Chapter 5
Relationships between blood pressure, fasting glucose concentrations
and microvascular structure and function
in healthy young men.
The studies described in the preceding chapters tested the hypothesis that altered
structure or function of microvessels mediated the association between low birthweight
and higher blood pressure, and did not find evidence to support this hypothesis. It may
be that capillary rarefaction develops later in the development of hypertension than
childhood or young adulthood. Structural or functional abnormalities of the
microcirculation have been postulated to influence insulin resistance as well as vascular
resistance by limiting glucose delivery to tissues (see section in introduction). Tooke
and Hattersley postulate (HATTERSLEY 1999) that diminished capillary network
development might occur as a consequence of foetal resistance to vascular growth
promotion by insulin. This would be an initiator of higher blood pressure because of
increased peripheral resistance, and would contribute to the development of metabolic
consequences of insulin resistance. This chapter describes an analysis of experimental
work performed by Dr. Joe Noon in our laboratory, relating microvascular structure and
function to indices ofblood pressure and glucose metabolism.
Serne et al. addressed this hypothesis in a small group of healthy normotensive subjects
aged 20-64 years (SERNE 1999) and demonstrated an association between insulin
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sensitivity and blood pressure and a strong relationship between both parameters and
microvascular function assessed by vasodilator responses to iontophoresis of
acetylcholine, and capillary recruitment following arterial occlusion. In order to
eliminate the possible confounding factors of age and sex in these findings, the present
study examined a large group of 105 healthy men aged 23-33 years.
Methods
Participants
These studies were approved by our local Research Ethics Committee and written
informed consent was obtained. Subjects were selected from a cohort which has been
described elsewhere (WATT 1991, WATT 1992). In brief, blood pressure was measured
in 603 married couples in 1979 and in 864 of their offspring, then aged 16-24 years, in
1986. Age-adjusted Z-scores were used to define tertiles for both offspring and mean
parental blood pressures. Offspring for whom both their own blood pressure and the
mean blood pressure of their parents were outwith the middle tertile were identified as
belonging to one of 'four corners'. Sub-groups of offspring randomly selected from these
corners have participated in further investigations (WATT 1992, NOON 1997) which
have identified correlates of the inherited predisposition to high blood pressure. We
studied 105 Caucasian male offspring drawn at random from the four corners.
Protocol
After an overnight fast from 2200 h, and abstention from proprietary drugs including
aspirin for 10 days, subjects attended the Clinical Research Centre at 0900 h. Height and
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weight were recorded before subjects rested supine and acclimatised to a controlled
environmental temperature of 23-24°C. After 20 minutes, a 30 ml venous blood sample
was obtained and recordings of blood pressure were made 4 times at 5 minute intervals
using a validated (WIINBERG 1988) semi-automated machine (Takeda UA 751
sphygmomanometer; Takeda Medical Inc., Tokyo, Japan). The means of the last three
recordings were used in subsequent analyses. After 40 minutes, the following
observations were made in sequence: (i) in the right arm, maximum vasodilatation of
skin microvessels was measured by laser Doppler fluximetry in response to local heating
to 42°C; (ii) in the left arm, nailfold capillary blood velocity and red cell column width,
and capillary numbers on the dorsum of the ring finger were measured by intravital
videomicroscopy; (iii) in the right arm, forearm blood flow was measured before and
after 12 minutes of ischemia applied using a sphygmanomometer at supra-systolic
pressure, using strain gauge plethysmography; (iv) in the left arm, dermal vasodilatation
was measured by laser Doppler fluximetry in response to transdermal delivery of
acetylcholine by iontophoresis.
Further details of measurements in these subjects have been published previously
(NOON 1997), except for iontophoresis and assessment of insulin sensitivity.
Iontophoresis was performed as previously validated in the same lab (NOON 1998).
Briefly, acetylcholine (Sigma Chemicals Ltd., Poole, Dorset, UK) was prepared in 2%
methylcellulose gel at a final concentration of 2 g/100 ml. Acetylcholine or vehicle (0.5
ml) were injected in random order into an iontophoresis chamber (Moor Instruments
Ltd., England) positioned on the volar aspect of the left forearm and flux was measured
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continuously by laser Doppler. Currents of increasing duration and intensity (100 pA for
10 s; 200 pA for 10 s; 200 pA for 20 s; 200 pA for 40 s; and 200 pA for 80 s) were
applied to deliver charges of 1, 2, 4, 8 and 16 mC. Response periods were allowed after
each charge (60 s for 1 and 2 mC, 90s for 4 mC, 120 s for 8 and 16 mC) which were
sufficient for the response to plateau consistently. The iontophoresis chamber was then
removed and cleaned before the procedure was repeated on a neighbouring site with the
next solution (drug or vehicle). Mean flux, measured at the plateau of the response for
each charge, was expressed in arbitrary flux units. We calculated % increase in flux and
area under the curve, and used both as summary statistics. However, there was no
difference between these measures for any relationship with iontophoretic response, and
% change in flux is quoted for all results. In preliminary experiments, laser Doppler
'biological zero' values were recorded during ischaemia, but flux values were negligible
in relation to the vasodilatation to iontophoresed drugs so we did not adjust for
biological zeros in this study.
Laboratory methods
Plasma was stored at -80°C until analysis. Insulin was measured by radio-immune assay
(WALKER 1995). Glucose was measured by autoanalyser. Insulin resistance was
estimated using the Homeostasis Model Assessment - HOMA. (MATTHEWS 1985)
Statistics
Comparison between subjects from the four corners was performed by ANOVA. Fasting
plasma insulin, HOMA resistance index and maximal forearm blood flow were log
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transformed to normalise their distribution. Correlations in the whole sample were
identified by linear regression. Multiple regression analysis was used to identify
confounding influences between interrelating variables.
Results
Summary of results and comparison between four corners
Characteristics of subjects were: age (28.7, ±2.5 years, 23-33; mean, standard deviation,
range); body mass index (BMI) (24.3, ±3.02, 18.6-36.8 kg/m2); systolic BP (119, ±9.7,
93-154 mmHg); diastolic BP (69.2, ±7.4, 51-98 mmHg); fasting plasma glucose (4.9,
±0.5, 3.0-6.5 mmol/1); fasting plasma insulin (5.3, ±4.5, 1.1-29.6 mUnits/1); and HOMA
Resistance index (14 *10"6, 12*10~6, 2-78* 10~6). Comparison of measurements of
microvascular structure in these members of the four corners has been published
previously (NOON 1997). Fasting plasma glucose was not different between corners
(ANOVA p=0.24), but there were trends for higher HOMA insulin resistance index
amongst subjects with higher blood pressure (ANOVA p=0.09), as previously described
in a different sample ofmen and women (WATT 1992).
Iontophoresis of acetylcholine caused dose dependent vasodilatation while there was no
significant dilatation with vehicle (Figure 5.1). There was no difference in response to
iontophoresis between the four corners (ANOVA p= 0.4)
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Iontophoresis charge (mC)
Fig 5.1 Graph of iontophoresis responses to acetylcholine.
This graph shows the dose dependant vasodilatation resulting from iontophoresis of drug
or vehicle. Measurements were made by laser Doppler fluximetry and expressed as
mean + standard error. (Repeated measures ANOVA p<0.001)
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Relationships with bloodpressure
Higher systolic blood pressure was associated with higher fasting plasma glucose
(r=0.21,p<0.05), and higher indices of insulin resistance (log fasting plasma insulin
r=0.32, p=0.001; log HOMA Resistance index r=0.31, p<0.005), and with higher body
mass index (r=0.25, p<0.01). Higher blood pressure was also associated with fewer
dermal capillaries at baseline and during venous occlusion, and reduced maximal flow
in dermal vessels. However, blood pressure did not correlate with maximal forearm
blood flow following ischaemia or dermal vascular vasodilatation to acetylcholine.
Diastolic Blood pressure similarly correlated with insulin resistance (log HOMA
r=0.21,p<0.05; log plasma insulin r=0.21, p<0.05) and with skin hyperemia, but not
other measurements ofmicrovascular structure or function. ( See Table 5.1)
Relationships with insulin sensitivity
(See Table 5.1). As expected, greater insulin resistance was associated with higher BMI
(r=0.53, p<0.001). There were no relationships between insulin resistance and indices of
dermal microvascular structure or response to acetylcholine. However, higher fasting
plasma glucose was associated with fewer dermal capillaries at baseline and during
venous occlusion, and with increased capillary blood velocity. These effects were
independent of systolic blood pressure in multiple regression analyses (r=-0.24, p<0.05
and r=-0.21, p<0.05 for plasma glucose versus capillary density at baseline and after
venous occlusion, respectively, r=0.29, p<0.01 for plasma glucose versus capillary
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Discussion
It is intellectually attractive to link the common, associated conditions of high blood
pressure and insulin resistance through shared abnormalities of microvascular structure
and function, causing on the one hand, increased peripheral vascular resistance and high
blood pressure, and on the other, impaired tissue delivery of glucose and insulin
resistance. Few would deny that insulin can stimulate skeletal muscle blood flow in
some circumstances, though controversy exists over its importance in the physiological
control of skeletal muscle glucose uptake. For example, an elegant study (LAINE 1998)
recently demonstrated that reversing the abnormality in insulin mediated vasodilatation
failed to improve glucose uptake in the legs of insulin resistant young men, and studies
have shown that other vasodilators do not improve insulin resistance.
Much of this controversy is likely to be explained by the lack of techniques sensitive
enough to measure muscle capillary flow in human subjects. Animal studies clearly
demonstrate, even in the absence of a change in total muscle flow, that insulin increases
nutritive capillary recruitment and improves glucose uptake. Conversely, increases in
total blood flow which bypass the nutritive capillary bed do not improve glucose uptake.
In humans, insulin increases skin capillary blood flow independent of any glucose
effects at least in subjects with type 1 diabetes (TOOKE 1985). If insulin mediated
vasodilatation is indeed important in the physiological regulation of glucose uptake, the
impaired insulin mediated vasodilatory responses described in hypertension and other
insulin resistant states such as obesity, ageing, and type 2 diabetes could contribute to
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insulin resistance. We have confirmed that insulin resistance and higher blood pressure
are correlated in our cohort of 105 healthy young men but we found no evidence that
microvascular structure or function influenced this relationship.
The relationships in our data between dermal microvascular structure and blood pressure
were consistent with many previously published studies (ANTONIOS 1999A, GASSER
1992, PRASAD 1995) supporting the theory first proposed by Folkow in 1958
(FOLKOW 1958) that structural distortions in microvascular networks maintain
increased peripheral vascular resistance.
We did not demonstrate relationships between blood pressure and microvascular
function assessed by responses to iontophoresis of acetylcholine. Previous descriptions
of endothelial dysfunction in hypertension have examined large arteries and the forearm
muscle bed where nitric oxide is the major mediator of acetylcholine related
vasodilatation (PANZA 1990). It is unlikely that iontophoresis of acetylcholine to
dermal vessels assesses purely nitric oxide dependent vasodilatation. We have
previously shown that blood flow assessed by laser Doppler in areas of skin that are
supplied by essentially nutritive microcirculation (ie dorsum of hand or ventral surface
of forearm) does not change during intra-arterial infusion of F-NMMA (NOON 1996).
Moreover, vasodilator responses to iontophoresis of acetylcholine in these areas are not
inhibited by F-NMMA (NOON 1992) although they may be inhibited by intravenous
(NOON 1998) but not oral aspirin (MORRIS 1996). Conversely, laser Doppler
fluximetry of flow in the pulp of the thumb, which has numerous thermoregulatory
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arteriovenous anastomoses, was decreased by 33% during L-NMMA infusion (NOON
1996).
In contrast with the strong associations with blood pressure there were no relationships
between markers of insulin resistance and dermal microvascular structure, (capillary
number pre or post venous occlusion, and hyperaemia following local skin heating) or
function (vasodilatation to acetylcholine). We have previously shown a correlation
between fasting insulin levels and skin hyperaemia in a group of normotensive men and
women with fasting hyperglycaemia, and a correlation between BMI and skin
hyperaemia in healthy normotensive men and women, (unpublished observations). The
influence of age and gender are the most likely explanations for the differences between
these studies since both factors may influence both vascular function and insulin
sensitivity. The lack of relationships with the skin microcirculation response to
acetylcholine agree with those of Petrie and colleagues (PETRIE 1996) who failed to
show a relationship between the forearm blood flow response to acetyl choline and
measures of insulin resistance in healthy male subjects.
These results contradict those of Serne et al. (SERNE 1999) who showed associations
between dermal microvascular function, blood pressure and insulin resistance. Several
factors may contribute to this disparity. The populations studied were different; we
studied 105 young men age 23- 35 while Serne studied just 18 men and women, with a
wide age range. Both age and gender are known to have marked effects on vascular
reactivity. Serne and colleagues quantified insulin sensitivity by euglycaemic
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hyperinsulinaemic clamp which was not logistically possible in our study. We used the
HOMA score which correlates closely with the result obtained by the clamp method
(MATTHEWS 1985). Since M values from a clamp are influenced by the initial glucose
concentration (BERGMAN 1985) our finding of a relationship between baseline
capillary numbers and fasting plasma glucose may be a relevant confounder of the
clamp results. Our study also differed from Serne et al. in the site where vessels were
studied; they used the nail fold to assess capillary density whereas we used the dorsum
of the finger. Nail fold capillaries are unusual in that they follow a prolonged course
parallel to the skin surface. The visible length varies between individuals as a function
of the degree of trauma to which their cuticles and nail folds are exposed. Capillary
density in the dorsal finger skin is greater (94/mm2 vs. 38.3/mm2) and not subjected to
this additional source of bias.
Serne et al describe relationships with % recruitment of capillaries during reactive
hyperaemia implying that this measurement relates to vascular function. Baseline
capillary perfusion chiefly depends upon skin temperature, which tends to be lower in
women despite acclimatisation to a temperature controlled environment, (unpublished
observation) Recruitment of capillaries following venous occlusion in dorsal finger skin
was much less than that observed in the nail fold following arterial occlusion (7.7% vs.
40.5%). Some of this discrepancy may result from the predominantly female group
studied by Serne, as their lower resting capillary number will have greater scope for
recruitment. However, Antonios et al (ANTONIOS 1999 B) found that capillary density
decreased during reactive hyperaemia following 5 minutes of arterial occlusion
123
(Ill/mm2 to 104/mm2) and that venous occlusion was the most effective way of
demonstrating recruitment (ANTONIOS 1999 B). It is therefore unclear what this index
actually represents.
Comparison of the strength of the relationship between insulin sensitivity and response
to iontophoresis of acetylcholine in our subjects with those of Serne can be done by
examining confidence intervals for the gradient of the regression. In the Dutch study, a
100% change in insulin sensitivity was associated with a 256% change in iontophoresis
response. Conversely in our study 95% confidence limits for a 100% change in insulin
sensitivity would be associated with 4% to 12% change in iontophoresis response.
Interestingly in the present study fasting plasma glucose, which is more a reflection of
impaired pancreatic (3-cell function than insulin resistance was independently associated
with lower dermal capillary density both before and after venous occlusion. This
reduction in capillary number was accompanied by an elevation in capillary blood
velocity with no change in red cell column width (a marker of capillary diameter)
suggesting that individual capillary blood flow is increased. Such an increase in flow
and associated increases in shear stress on the endothelial cell may have profound
effects on capillary function.
In summary, we have demonstrated strong links between microvascular structure and
blood pressure in healthy young men that may play an important role in the familial
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inheritence of high blood pressure. By contrast we found no relationship linking
microvascular structure or function to insulin resistance.
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Chapter 6: Conclusions and Speculations
This thesis has considered the role of structural changes in the microvasculature as a
programmed mediator of the association between low birthweight and high blood
pressure. We have found no evidence to support this hypothesis in two separate studies
of capillary density, but have shown evidence that individuals born prematurely have
greater left ventricular mass, over and above that predicted by their elevated blood
pressure. We have also shown evidence of elevated blood lipids and fasting plasma
glucose in premature low birthweight babies but no evidence of insulin resistance.
Furthermore, we have demonstrated that low birthweight predicts higher blood pressure
in a cohort drawn from a narrow and relatively privileged social spectrum. Finally we
have considered evidence considering whether insulin resistance might be mediated
through vascular responses in the dermal microvessels. This final chapter will briefly
consider some of the broader issues.
Public Health Importance
The "foetal origins" hypothesis as an explanation for the burden of cardiovascular
disease gains little support from ecologic trends. Cardiovascular disease has followed an
epidemic dissemination through industrialised countries during the 20th Century. It has
followed trends of altered diet, exercise and, perhaps most importantly cigarette
smoking. No trends of diminished birthweight have been demonstrated preceding the
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rise in incidence of clinical manifestations of vascular pathology. The decline in disease
incidence during the latter decades was not preceded by a major rise in birthweight.
Birthweights tend to be high in the Northern European countries that have had the
greatest incidence of cardiovascular disease.
The small influence of birthweight on adult outcomes should reassure individuals with
low birthweight that their expectation of future good health remains intact, and efforts to
encourage and maintain healthy habits are equally relevant to all sectors of the
population.
Gestational Age, IUGR and Catch-up growth
That disparate processes occurring during foetal or infant life can be shown to associate
with higher adult blood pressure challenges reductionism. The relationship between size
at birth and adult blood pressure depends upon the whole range of birthweight, and it
seems logical that the explanation of the association might encompass more than one of
the influences on birthweight. We have demonstrated, in a small study, that premature
delivery can be associated with higher blood pressure. Very large studies have also
demonstrated this, however several have not shown an influence from gestation.
Similarly, in our study of premature babies there was no influence from growth between
birth and the adult measurements, although this is important in many studies.
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Reconciling differences in these studies requires recognition that the effect size is small,
and large studies will be best able to precisely define the true effect of these variables.
Opportunistic use of routinely collected data linked through unique national
identification numbers has provided the largest study published to date. Accessing
childhood growth records could add the data required to definitively calculate the
contributions that these separate biological processes add to the association in question.
Truly prospective studies with the scale to settle these questions would require resources
exceeding the scientific merits of their purpose. The influence of birthweight on lifetime
risk of cardiovascular morbidity and mortality is small and unlikely to be amenable to
simple, safe interventions. The value of studies in this area is the insights gained from
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